AU2004226939B2 - Conformable tissue repair implant capable of injection delivery - Google Patents
Conformable tissue repair implant capable of injection delivery Download PDFInfo
- Publication number
- AU2004226939B2 AU2004226939B2 AU2004226939A AU2004226939A AU2004226939B2 AU 2004226939 B2 AU2004226939 B2 AU 2004226939B2 AU 2004226939 A AU2004226939 A AU 2004226939A AU 2004226939 A AU2004226939 A AU 2004226939A AU 2004226939 B2 AU2004226939 B2 AU 2004226939B2
- Authority
- AU
- Australia
- Prior art keywords
- tissue
- implant
- cells
- granules
- carrier matrix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000007943 implant Substances 0.000 title claims description 167
- 230000017423 tissue regeneration Effects 0.000 title claims description 60
- 238000002347 injection Methods 0.000 title description 13
- 239000007924 injection Substances 0.000 title description 13
- 210000001519 tissue Anatomy 0.000 claims description 287
- 239000012634 fragment Substances 0.000 claims description 92
- 239000008187 granular material Substances 0.000 claims description 84
- 210000004027 cell Anatomy 0.000 claims description 69
- 238000000034 method Methods 0.000 claims description 69
- 239000011159 matrix material Substances 0.000 claims description 57
- -1 copoly(ether-esters) Substances 0.000 claims description 49
- 210000000845 cartilage Anatomy 0.000 claims description 39
- 239000003795 chemical substances by application Substances 0.000 claims description 31
- 230000007547 defect Effects 0.000 claims description 28
- 239000002245 particle Substances 0.000 claims description 26
- 108090000623 proteins and genes Proteins 0.000 claims description 24
- 229920001577 copolymer Polymers 0.000 claims description 23
- 238000002513 implantation Methods 0.000 claims description 22
- 239000000725 suspension Substances 0.000 claims description 22
- 108010080379 Fibrin Tissue Adhesive Proteins 0.000 claims description 21
- 239000000853 adhesive Substances 0.000 claims description 21
- 230000001070 adhesive effect Effects 0.000 claims description 21
- 230000006378 damage Effects 0.000 claims description 21
- 208000027418 Wounds and injury Diseases 0.000 claims description 20
- 239000011230 binding agent Substances 0.000 claims description 20
- 208000014674 injury Diseases 0.000 claims description 20
- 102000004169 proteins and genes Human genes 0.000 claims description 20
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 18
- 239000003102 growth factor Substances 0.000 claims description 18
- 239000007787 solid Substances 0.000 claims description 17
- 210000001612 chondrocyte Anatomy 0.000 claims description 16
- 241000700605 Viruses Species 0.000 claims description 13
- 210000003041 ligament Anatomy 0.000 claims description 13
- PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical compound O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 claims description 11
- 210000000988 bone and bone Anatomy 0.000 claims description 10
- 239000012530 fluid Substances 0.000 claims description 10
- 210000002435 tendon Anatomy 0.000 claims description 10
- 102100034221 Growth-regulated alpha protein Human genes 0.000 claims description 9
- 101001069921 Homo sapiens Growth-regulated alpha protein Proteins 0.000 claims description 9
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 9
- AFOSIXZFDONLBT-UHFFFAOYSA-N divinyl sulfone Chemical compound C=CS(=O)(=O)C=C AFOSIXZFDONLBT-UHFFFAOYSA-N 0.000 claims description 9
- 108020004707 nucleic acids Proteins 0.000 claims description 9
- 102000039446 nucleic acids Human genes 0.000 claims description 9
- 150000007523 nucleic acids Chemical class 0.000 claims description 9
- 102000004190 Enzymes Human genes 0.000 claims description 8
- 108090000790 Enzymes Proteins 0.000 claims description 8
- 239000011575 calcium Substances 0.000 claims description 8
- 150000001875 compounds Chemical class 0.000 claims description 8
- 229940088598 enzyme Drugs 0.000 claims description 8
- 210000004623 platelet-rich plasma Anatomy 0.000 claims description 8
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 7
- 108010035532 Collagen Proteins 0.000 claims description 7
- 102000008186 Collagen Human genes 0.000 claims description 7
- 229910052791 calcium Inorganic materials 0.000 claims description 7
- 229920001436 collagen Polymers 0.000 claims description 7
- 229920001223 polyethylene glycol Polymers 0.000 claims description 7
- 229920001282 polysaccharide Polymers 0.000 claims description 7
- 239000005017 polysaccharide Substances 0.000 claims description 7
- 210000000130 stem cell Anatomy 0.000 claims description 7
- 102000009027 Albumins Human genes 0.000 claims description 6
- 108010088751 Albumins Proteins 0.000 claims description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 6
- 108010010803 Gelatin Proteins 0.000 claims description 6
- 108090000190 Thrombin Proteins 0.000 claims description 6
- 239000012190 activator Substances 0.000 claims description 6
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 claims description 6
- 229920003232 aliphatic polyester Polymers 0.000 claims description 6
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 claims description 6
- 229920002678 cellulose Polymers 0.000 claims description 6
- 239000001913 cellulose Substances 0.000 claims description 6
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 6
- 229930195729 fatty acid Natural products 0.000 claims description 6
- 239000000194 fatty acid Substances 0.000 claims description 6
- 210000002950 fibroblast Anatomy 0.000 claims description 6
- 229920000159 gelatin Polymers 0.000 claims description 6
- 239000008273 gelatin Substances 0.000 claims description 6
- 235000019322 gelatine Nutrition 0.000 claims description 6
- 235000011852 gelatine desserts Nutrition 0.000 claims description 6
- 150000004676 glycans Chemical class 0.000 claims description 6
- 229920002674 hyaluronan Polymers 0.000 claims description 6
- 229960004072 thrombin Drugs 0.000 claims description 6
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 5
- 229920002683 Glycosaminoglycan Polymers 0.000 claims description 5
- 108010067787 Proteoglycans Proteins 0.000 claims description 5
- 102000016611 Proteoglycans Human genes 0.000 claims description 5
- 230000000735 allogeneic effect Effects 0.000 claims description 5
- 210000002808 connective tissue Anatomy 0.000 claims description 5
- 239000005556 hormone Substances 0.000 claims description 5
- 229940088597 hormone Drugs 0.000 claims description 5
- 229960003160 hyaluronic acid Drugs 0.000 claims description 5
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 5
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 5
- KKGSHHDRPRINNY-UHFFFAOYSA-N 1,4-dioxan-2-one Chemical compound O=C1COCCO1.O=C1COCCO1 KKGSHHDRPRINNY-UHFFFAOYSA-N 0.000 claims description 4
- 102000016942 Elastin Human genes 0.000 claims description 4
- 108010014258 Elastin Proteins 0.000 claims description 4
- 108010085895 Laminin Proteins 0.000 claims description 4
- 102000007547 Laminin Human genes 0.000 claims description 4
- 239000002202 Polyethylene glycol Substances 0.000 claims description 4
- 239000003242 anti bacterial agent Substances 0.000 claims description 4
- 229940088710 antibiotic agent Drugs 0.000 claims description 4
- 239000004599 antimicrobial Substances 0.000 claims description 4
- 229960005069 calcium Drugs 0.000 claims description 4
- 229920002549 elastin Polymers 0.000 claims description 4
- 230000005499 meniscus Effects 0.000 claims description 4
- 210000004409 osteocyte Anatomy 0.000 claims description 4
- 210000004180 plasmocyte Anatomy 0.000 claims description 4
- 229920002627 poly(phosphazenes) Polymers 0.000 claims description 4
- RQPKNXVVIBYOBX-KDBLBPRBSA-N (2s)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid;(2s)-2-(dihydroxyamino)-3-phenylpropanoic acid Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1.ON(O)[C@H](C(O)=O)CC1=CC=CC=C1 RQPKNXVVIBYOBX-KDBLBPRBSA-N 0.000 claims description 3
- WCDDVEOXEIYWFB-VXORFPGASA-N (2s,3s,4r,5r,6r)-3-[(2s,3r,5s,6r)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O)[C@H](O)[C@H]1O WCDDVEOXEIYWFB-VXORFPGASA-N 0.000 claims description 3
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 claims description 3
- 229930182837 (R)-adrenaline Natural products 0.000 claims description 3
- UJGHGRGFKZWGMS-UHFFFAOYSA-N 1,3-dioxan-2-one Chemical compound O=C1OCCCO1.O=C1OCCCO1 UJGHGRGFKZWGMS-UHFFFAOYSA-N 0.000 claims description 3
- XSCDOEBLKZJZLX-UHFFFAOYSA-N 1-ethenylsulfonylethene;2-hydroxyethyl 2-methylprop-2-enoate Chemical compound C=CS(=O)(=O)C=C.CC(=C)C(=O)OCCO XSCDOEBLKZJZLX-UHFFFAOYSA-N 0.000 claims description 3
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims description 3
- 229920000936 Agarose Polymers 0.000 claims description 3
- 239000002126 C01EB10 - Adenosine Substances 0.000 claims description 3
- 229920002101 Chitin Polymers 0.000 claims description 3
- 229920001661 Chitosan Polymers 0.000 claims description 3
- 241000251730 Chondrichthyes Species 0.000 claims description 3
- 102000004127 Cytokines Human genes 0.000 claims description 3
- 108090000695 Cytokines Proteins 0.000 claims description 3
- 108010073385 Fibrin Proteins 0.000 claims description 3
- 102000009123 Fibrin Human genes 0.000 claims description 3
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 claims description 3
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims description 3
- 102000005755 Intercellular Signaling Peptides and Proteins Human genes 0.000 claims description 3
- 108010070716 Intercellular Signaling Peptides and Proteins Proteins 0.000 claims description 3
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 claims description 3
- 229910019142 PO4 Inorganic materials 0.000 claims description 3
- 229920002732 Polyanhydride Polymers 0.000 claims description 3
- 108010081391 Ristocetin Proteins 0.000 claims description 3
- 208000007536 Thrombosis Diseases 0.000 claims description 3
- 108060008539 Transglutaminase Proteins 0.000 claims description 3
- 229960005305 adenosine Drugs 0.000 claims description 3
- 210000001789 adipocyte Anatomy 0.000 claims description 3
- 150000001299 aldehydes Chemical class 0.000 claims description 3
- 229940072056 alginate Drugs 0.000 claims description 3
- 229920000615 alginic acid Polymers 0.000 claims description 3
- 235000010443 alginic acid Nutrition 0.000 claims description 3
- 125000000217 alkyl group Chemical group 0.000 claims description 3
- 229940035676 analgesics Drugs 0.000 claims description 3
- 239000000730 antalgic agent Substances 0.000 claims description 3
- 239000002260 anti-inflammatory agent Substances 0.000 claims description 3
- 229940121363 anti-inflammatory agent Drugs 0.000 claims description 3
- 239000003963 antioxidant agent Substances 0.000 claims description 3
- 235000006708 antioxidants Nutrition 0.000 claims description 3
- 229940114079 arachidonic acid Drugs 0.000 claims description 3
- 235000021342 arachidonic acid Nutrition 0.000 claims description 3
- 150000001502 aryl halides Chemical class 0.000 claims description 3
- 229940072107 ascorbate Drugs 0.000 claims description 3
- 235000010323 ascorbic acid Nutrition 0.000 claims description 3
- 239000011668 ascorbic acid Substances 0.000 claims description 3
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 claims description 3
- 210000002798 bone marrow cell Anatomy 0.000 claims description 3
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 claims description 3
- 150000001718 carbodiimides Chemical class 0.000 claims description 3
- BGTFCAQCKWKTRL-YDEUACAXSA-N chembl1095986 Chemical compound C1[C@@H](N)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]([C@H]1C(N[C@H](C2=CC(O)=CC(O[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=C2C=2C(O)=CC=C(C=2)[C@@H](NC(=O)[C@@H]2NC(=O)[C@@H]3C=4C=C(C(=C(O)C=4)C)OC=4C(O)=CC=C(C=4)[C@@H](N)C(=O)N[C@@H](C(=O)N3)[C@H](O)C=3C=CC(O4)=CC=3)C(=O)N1)C(O)=O)=O)C(C=C1)=CC=C1OC1=C(O[C@@H]3[C@H]([C@H](O)[C@@H](O)[C@H](CO[C@@H]5[C@H]([C@@H](O)[C@H](O)[C@@H](C)O5)O)O3)O[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O[C@@H]3[C@H]([C@H](O)[C@@H](CO)O3)O)C4=CC2=C1 BGTFCAQCKWKTRL-YDEUACAXSA-N 0.000 claims description 3
- 229960005188 collagen Drugs 0.000 claims description 3
- 210000004207 dermis Anatomy 0.000 claims description 3
- 210000002889 endothelial cell Anatomy 0.000 claims description 3
- 229960005139 epinephrine Drugs 0.000 claims description 3
- 210000002919 epithelial cell Anatomy 0.000 claims description 3
- 229950003499 fibrin Drugs 0.000 claims description 3
- 210000003630 histaminocyte Anatomy 0.000 claims description 3
- 229920001519 homopolymer Polymers 0.000 claims description 3
- 229940014041 hyaluronate Drugs 0.000 claims description 3
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 claims description 3
- 150000002463 imidates Chemical class 0.000 claims description 3
- 229960003444 immunosuppressant agent Drugs 0.000 claims description 3
- 239000003018 immunosuppressive agent Substances 0.000 claims description 3
- 229940102213 injectable suspension Drugs 0.000 claims description 3
- 239000012948 isocyanate Substances 0.000 claims description 3
- 150000002513 isocyanates Chemical class 0.000 claims description 3
- 210000000265 leukocyte Anatomy 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 210000002540 macrophage Anatomy 0.000 claims description 3
- 108010082117 matrigel Proteins 0.000 claims description 3
- 229910021645 metal ion Inorganic materials 0.000 claims description 3
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 claims description 3
- 210000001616 monocyte Anatomy 0.000 claims description 3
- 210000004877 mucosa Anatomy 0.000 claims description 3
- 210000001074 muscle attachment cell Anatomy 0.000 claims description 3
- 210000003098 myoblast Anatomy 0.000 claims description 3
- 210000000963 osteoblast Anatomy 0.000 claims description 3
- 210000002997 osteoclast Anatomy 0.000 claims description 3
- 239000010452 phosphate Substances 0.000 claims description 3
- 210000002381 plasma Anatomy 0.000 claims description 3
- 229920003213 poly(N-isopropyl acrylamide) Polymers 0.000 claims description 3
- 229920001308 poly(aminoacid) Polymers 0.000 claims description 3
- 229920000058 polyacrylate Polymers 0.000 claims description 3
- 229920001451 polypropylene glycol Polymers 0.000 claims description 3
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 3
- 229950004257 ristocetin Drugs 0.000 claims description 3
- 150000003384 small molecules Chemical class 0.000 claims description 3
- 239000000021 stimulant Substances 0.000 claims description 3
- 210000002536 stromal cell Anatomy 0.000 claims description 3
- 239000001384 succinic acid Substances 0.000 claims description 3
- 102000003601 transglutaminase Human genes 0.000 claims description 3
- 150000003626 triacylglycerols Chemical class 0.000 claims description 3
- 210000003954 umbilical cord Anatomy 0.000 claims description 3
- 230000029663 wound healing Effects 0.000 claims description 3
- 102100026735 Coagulation factor VIII Human genes 0.000 claims description 2
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 claims description 2
- 241000237536 Mytilus edulis Species 0.000 claims description 2
- 239000011248 coating agent Substances 0.000 claims description 2
- 238000000576 coating method Methods 0.000 claims description 2
- 235000020638 mussel Nutrition 0.000 claims description 2
- RMZNXRYIFGTWPF-UHFFFAOYSA-N 2-nitrosoacetic acid Chemical compound OC(=O)CN=O RMZNXRYIFGTWPF-UHFFFAOYSA-N 0.000 claims 2
- 239000004698 Polyethylene Substances 0.000 claims 2
- 239000000560 biocompatible material Substances 0.000 claims 2
- 239000000512 collagen gel Substances 0.000 claims 2
- 235000019197 fats Nutrition 0.000 claims 2
- 210000002901 mesenchymal stem cell Anatomy 0.000 claims 2
- 229920000573 polyethylene Polymers 0.000 claims 2
- 150000003180 prostaglandins Chemical class 0.000 claims 2
- 230000003746 surface roughness Effects 0.000 claims 1
- 229920000954 Polyglycolide Polymers 0.000 description 18
- 239000004633 polyglycolic acid Substances 0.000 description 18
- 239000012636 effector Substances 0.000 description 15
- 229920000642 polymer Polymers 0.000 description 14
- 238000001356 surgical procedure Methods 0.000 description 14
- 239000002131 composite material Substances 0.000 description 13
- 239000000203 mixture Substances 0.000 description 13
- 230000035876 healing Effects 0.000 description 12
- 230000010261 cell growth Effects 0.000 description 10
- 238000000338 in vitro Methods 0.000 description 10
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 10
- 230000001413 cellular effect Effects 0.000 description 9
- 230000008439 repair process Effects 0.000 description 9
- 230000007838 tissue remodeling Effects 0.000 description 9
- 238000011282 treatment Methods 0.000 description 9
- 229920001198 elastomeric copolymer Polymers 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 208000037816 tissue injury Diseases 0.000 description 8
- RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 description 7
- 230000008901 benefit Effects 0.000 description 7
- 239000000499 gel Substances 0.000 description 7
- JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 description 7
- YFHICDDUDORKJB-UHFFFAOYSA-N trimethylene carbonate Chemical compound O=C1OCCCO1 YFHICDDUDORKJB-UHFFFAOYSA-N 0.000 description 7
- JJTUDXZGHPGLLC-IMJSIDKUSA-N 4511-42-6 Chemical compound C[C@@H]1OC(=O)[C@H](C)OC1=O JJTUDXZGHPGLLC-IMJSIDKUSA-N 0.000 description 6
- 230000003416 augmentation Effects 0.000 description 6
- 210000003491 skin Anatomy 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 230000003612 virological effect Effects 0.000 description 6
- VPVXHAANQNHFSF-UHFFFAOYSA-N 1,4-dioxan-2-one Chemical compound O=C1COCCO1 VPVXHAANQNHFSF-UHFFFAOYSA-N 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 230000000295 complement effect Effects 0.000 description 5
- 235000014655 lactic acid Nutrition 0.000 description 5
- 239000004310 lactic acid Substances 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 238000002324 minimally invasive surgery Methods 0.000 description 5
- 241000283690 Bos taurus Species 0.000 description 4
- 230000003139 buffering effect Effects 0.000 description 4
- 229920001971 elastomer Polymers 0.000 description 4
- 239000000806 elastomer Substances 0.000 description 4
- 238000003306 harvesting Methods 0.000 description 4
- 230000008929 regeneration Effects 0.000 description 4
- 238000011069 regeneration method Methods 0.000 description 4
- 108091005804 Peptidases Proteins 0.000 description 3
- 102000035195 Peptidases Human genes 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 239000003124 biologic agent Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000014509 gene expression Effects 0.000 description 3
- 230000010354 integration Effects 0.000 description 3
- 239000003446 ligand Substances 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 102000005962 receptors Human genes 0.000 description 3
- 108020003175 receptors Proteins 0.000 description 3
- 230000001172 regenerating effect Effects 0.000 description 3
- 238000007873 sieving Methods 0.000 description 3
- BYEAHWXPCBROCE-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-ol Chemical compound FC(F)(F)C(O)C(F)(F)F BYEAHWXPCBROCE-UHFFFAOYSA-N 0.000 description 2
- 102000029816 Collagenase Human genes 0.000 description 2
- 108060005980 Collagenase Proteins 0.000 description 2
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 108090000288 Glycoproteins Proteins 0.000 description 2
- 102000003886 Glycoproteins Human genes 0.000 description 2
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 2
- 102000004895 Lipoproteins Human genes 0.000 description 2
- 108090001030 Lipoproteins Proteins 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 108010005246 Tissue Inhibitor of Metalloproteinases Proteins 0.000 description 2
- 102000005876 Tissue Inhibitor of Metalloproteinases Human genes 0.000 description 2
- 210000000577 adipose tissue Anatomy 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000003190 augmentative effect Effects 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 239000000227 bioadhesive Substances 0.000 description 2
- 230000031018 biological processes and functions Effects 0.000 description 2
- 238000001574 biopsy Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000001185 bone marrow Anatomy 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 230000012292 cell migration Effects 0.000 description 2
- 229960002424 collagenase Drugs 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 210000002744 extracellular matrix Anatomy 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 230000000921 morphogenic effect Effects 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000007634 remodeling Methods 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 210000005222 synovial tissue Anatomy 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000008467 tissue growth Effects 0.000 description 2
- 238000009966 trimming Methods 0.000 description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 210000003771 C cell Anatomy 0.000 description 1
- 102000000905 Cadherin Human genes 0.000 description 1
- 108050007957 Cadherin Proteins 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 108010023736 Chondroitinases and Chondroitin Lyases Proteins 0.000 description 1
- 102000011413 Chondroitinases and Chondroitin Lyases Human genes 0.000 description 1
- 206010061762 Chondropathy Diseases 0.000 description 1
- 239000004971 Cross linker Substances 0.000 description 1
- 241000450599 DNA viruses Species 0.000 description 1
- 229920000045 Dermatan sulfate Polymers 0.000 description 1
- 102000002045 Endothelin Human genes 0.000 description 1
- 108050009340 Endothelin Proteins 0.000 description 1
- 101800003838 Epidermal growth factor Proteins 0.000 description 1
- 102400001368 Epidermal growth factor Human genes 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 102000018233 Fibroblast Growth Factor Human genes 0.000 description 1
- 108050007372 Fibroblast Growth Factor Proteins 0.000 description 1
- 108090000368 Fibroblast growth factor 8 Proteins 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- 102000016359 Fibronectins Human genes 0.000 description 1
- 108060003393 Granulin Proteins 0.000 description 1
- 229920002971 Heparan sulfate Polymers 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 102000003745 Hepatocyte Growth Factor Human genes 0.000 description 1
- 108090000100 Hepatocyte Growth Factor Proteins 0.000 description 1
- 108010003272 Hyaluronate lyase Proteins 0.000 description 1
- 102000001974 Hyaluronidases Human genes 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
- 229920000288 Keratan sulfate Polymers 0.000 description 1
- 108010006035 Metalloproteases Proteins 0.000 description 1
- 102000005741 Metalloproteases Human genes 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000002151 Microfilament Proteins Human genes 0.000 description 1
- 108010040897 Microfilament Proteins Proteins 0.000 description 1
- 108060008487 Myosin Proteins 0.000 description 1
- 102000003505 Myosin Human genes 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 108010067372 Pancreatic elastase Proteins 0.000 description 1
- 102000016387 Pancreatic elastase Human genes 0.000 description 1
- 108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 1
- 102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 1
- 102100039277 Pleiotrophin Human genes 0.000 description 1
- 102000003923 Protein Kinase C Human genes 0.000 description 1
- 108090000315 Protein Kinase C Proteins 0.000 description 1
- 208000024288 Rotator Cuff injury Diseases 0.000 description 1
- 102000003800 Selectins Human genes 0.000 description 1
- 108090000184 Selectins Proteins 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 102000013275 Somatomedins Human genes 0.000 description 1
- 102000007000 Tenascin Human genes 0.000 description 1
- 108010008125 Tenascin Proteins 0.000 description 1
- 108090001109 Thermolysin Proteins 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108010031318 Vitronectin Proteins 0.000 description 1
- 102100035140 Vitronectin Human genes 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 230000003305 autocrine Effects 0.000 description 1
- 229920002988 biodegradable polymer Polymers 0.000 description 1
- 239000004621 biodegradable polymer Substances 0.000 description 1
- 239000003364 biologic glue Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000008512 biological response Effects 0.000 description 1
- 210000005068 bladder tissue Anatomy 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007975 buffered saline Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 210000003321 cartilage cell Anatomy 0.000 description 1
- 238000012832 cell culture technique Methods 0.000 description 1
- 230000004709 cell invasion Effects 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 230000033077 cellular process Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000002648 chondrogenic effect Effects 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000001804 debridement Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- AVJBPWGFOQAPRH-FWMKGIEWSA-L dermatan sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS([O-])(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C([O-])=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-L 0.000 description 1
- 229940051593 dermatan sulfate Drugs 0.000 description 1
- 229960002986 dinoprostone Drugs 0.000 description 1
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 108010007093 dispase Proteins 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 241001493065 dsRNA viruses Species 0.000 description 1
- ZUBDGKVDJUIMQQ-UBFCDGJISA-N endothelin-1 Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)NC(=O)[C@H]1NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@@H](CC=2C=CC(O)=CC=2)NC(=O)[C@H](C(C)C)NC(=O)[C@H]2CSSC[C@@H](C(N[C@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N2)=O)NC(=O)[C@@H](CO)NC(=O)[C@H](N)CSSC1)C1=CNC=N1 ZUBDGKVDJUIMQQ-UBFCDGJISA-N 0.000 description 1
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
- 229940116977 epidermal growth factor Drugs 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 108060002895 fibrillin Proteins 0.000 description 1
- 102000013370 fibrillin Human genes 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 229940126864 fibroblast growth factor Drugs 0.000 description 1
- 210000000968 fibrocartilage Anatomy 0.000 description 1
- 238000001415 gene therapy Methods 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 239000011121 hardwood Substances 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 description 1
- 229940099552 hyaluronan Drugs 0.000 description 1
- 229960002773 hyaluronidase Drugs 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 102000006495 integrins Human genes 0.000 description 1
- 108010044426 integrins Proteins 0.000 description 1
- 210000003963 intermediate filament Anatomy 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- KXCLCNHUUKTANI-RBIYJLQWSA-N keratan Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@H](COS(O)(=O)=O)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H]([C@@H](COS(O)(=O)=O)O[C@@H](O)[C@@H]3O)O)[C@H](NC(C)=O)[C@H]2O)COS(O)(=O)=O)O[C@H](COS(O)(=O)=O)[C@@H]1O KXCLCNHUUKTANI-RBIYJLQWSA-N 0.000 description 1
- 239000006194 liquid suspension Substances 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 210000003632 microfilament Anatomy 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 210000002346 musculoskeletal system Anatomy 0.000 description 1
- 210000000944 nerve tissue Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 210000004923 pancreatic tissue Anatomy 0.000 description 1
- 230000003076 paracrine Effects 0.000 description 1
- 230000003239 periodontal effect Effects 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000000135 prohibitive effect Effects 0.000 description 1
- AAEVYOVXGOFMJO-UHFFFAOYSA-N prometryn Chemical compound CSC1=NC(NC(C)C)=NC(NC(C)C)=N1 AAEVYOVXGOFMJO-UHFFFAOYSA-N 0.000 description 1
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000004627 regenerated cellulose Substances 0.000 description 1
- 239000012779 reinforcing material Substances 0.000 description 1
- 210000005084 renal tissue Anatomy 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000002311 subsequent effect Effects 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 238000011477 surgical intervention Methods 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 229940033618 tisseel Drugs 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 239000003656 tris buffered saline Substances 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 239000013603 viral vector Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
- A61L27/3843—Connective tissue
- A61L27/3852—Cartilage, e.g. meniscus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/58—Materials at least partially resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Botany (AREA)
- Zoology (AREA)
- Physical Education & Sports Medicine (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Communicable Diseases (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Biochemistry (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Toxicology (AREA)
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/723,982 US7316822B2 (en) | 2003-11-26 | 2003-11-26 | Conformable tissue repair implant capable of injection delivery |
| US10/723,982 | 2003-11-26 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2004226939A1 AU2004226939A1 (en) | 2005-06-09 |
| AU2004226939B2 true AU2004226939B2 (en) | 2007-06-28 |
Family
ID=34465719
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2004226939A Ceased AU2004226939B2 (en) | 2003-11-26 | 2004-11-03 | Conformable tissue repair implant capable of injection delivery |
Country Status (6)
| Country | Link |
|---|---|
| US (4) | US7316822B2 (https=) |
| EP (2) | EP1535633B1 (https=) |
| JP (1) | JP4628756B2 (https=) |
| AU (1) | AU2004226939B2 (https=) |
| CA (1) | CA2487029C (https=) |
| DE (1) | DE602004029542D1 (https=) |
Families Citing this family (223)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020095157A1 (en) * | 1999-07-23 | 2002-07-18 | Bowman Steven M. | Graft fixation device combination |
| US6179840B1 (en) | 1999-07-23 | 2001-01-30 | Ethicon, Inc. | Graft fixation device and method |
| CA2365376C (en) * | 2000-12-21 | 2006-03-28 | Ethicon, Inc. | Use of reinforced foam implants with enhanced integrity for soft tissue repair and regeneration |
| US20040078090A1 (en) * | 2002-10-18 | 2004-04-22 | Francois Binette | Biocompatible scaffolds with tissue fragments |
| US7824701B2 (en) * | 2002-10-18 | 2010-11-02 | Ethicon, Inc. | Biocompatible scaffold for ligament or tendon repair |
| FR2850282B1 (fr) | 2003-01-27 | 2007-04-06 | Jerome Asius | Implant injectable a base de ceramique pour le comblement de rides, depressions cutanees et cicatrices, et sa preparation |
| US8197837B2 (en) | 2003-03-07 | 2012-06-12 | Depuy Mitek, Inc. | Method of preparation of bioabsorbable porous reinforced tissue implants and implants thereof |
| US7794408B2 (en) * | 2003-03-28 | 2010-09-14 | Ethicon, Inc. | Tissue collection device and methods |
| US20050222687A1 (en) * | 2004-04-02 | 2005-10-06 | Gordana Vunjak-Novakovic | Cartilage implant assembly and method for implantation |
| US20050064042A1 (en) * | 2003-04-29 | 2005-03-24 | Musculoskeletal Transplant Foundation | Cartilage implant plug with fibrin glue and method for implantation |
| US7067123B2 (en) | 2003-04-29 | 2006-06-27 | Musculoskeletal Transplant Foundation | Glue for cartilage repair |
| US20090291112A1 (en) * | 2003-05-16 | 2009-11-26 | Truncale Katherine G | Allograft osteochondral plug combined with cartilage particle mixture |
| US7901457B2 (en) * | 2003-05-16 | 2011-03-08 | Musculoskeletal Transplant Foundation | Cartilage allograft plug |
| US8226715B2 (en) | 2003-06-30 | 2012-07-24 | Depuy Mitek, Inc. | Scaffold for connective tissue repair |
| JP4673305B2 (ja) * | 2003-08-11 | 2011-04-20 | ウィルソン−クック・メディカル・インコーポレーテッド | 外科処置用移植片 |
| US10583220B2 (en) * | 2003-08-11 | 2020-03-10 | DePuy Synthes Products, Inc. | Method and apparatus for resurfacing an articular surface |
| US7611473B2 (en) * | 2003-09-11 | 2009-11-03 | Ethicon, Inc. | Tissue extraction and maceration device |
| US8034003B2 (en) * | 2003-09-11 | 2011-10-11 | Depuy Mitek, Inc. | Tissue extraction and collection device |
| US7316822B2 (en) | 2003-11-26 | 2008-01-08 | Ethicon, Inc. | Conformable tissue repair implant capable of injection delivery |
| US7901461B2 (en) | 2003-12-05 | 2011-03-08 | Ethicon, Inc. | Viable tissue repair implants and methods of use |
| US7824711B2 (en) | 2003-12-11 | 2010-11-02 | Isto Technologies, Inc. | Particulate cartilage system |
| KR100531922B1 (ko) * | 2003-12-23 | 2005-11-29 | 주식회사 셀론텍 | 연골치료제 조성물 및 그 사용방법 |
| US8084513B2 (en) * | 2003-12-30 | 2011-12-27 | Beisang Arthur A | Implant filling material and method |
| US7988986B2 (en) * | 2003-12-30 | 2011-08-02 | Beisang Arthur A | Implant filling material and method |
| US11395865B2 (en) * | 2004-02-09 | 2022-07-26 | DePuy Synthes Products, Inc. | Scaffolds with viable tissue |
| US8597352B2 (en) * | 2004-03-03 | 2013-12-03 | Schwartz Biomedical, Llc | Articular cartilage fixation device and method |
| US8137686B2 (en) * | 2004-04-20 | 2012-03-20 | Depuy Mitek, Inc. | Nonwoven tissue scaffold |
| US8221780B2 (en) * | 2004-04-20 | 2012-07-17 | Depuy Mitek, Inc. | Nonwoven tissue scaffold |
| US8512730B2 (en) | 2004-07-12 | 2013-08-20 | Isto Technologies, Inc. | Methods of tissue repair and compositions therefor |
| WO2006036984A2 (en) | 2004-09-28 | 2006-04-06 | Atrium Medical Corporation | Stand-alone film and methods for making the same |
| US9012506B2 (en) | 2004-09-28 | 2015-04-21 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
| US9000040B2 (en) | 2004-09-28 | 2015-04-07 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
| US20090319045A1 (en) | 2004-10-12 | 2009-12-24 | Truncale Katherine G | Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles |
| US20080220044A1 (en) * | 2007-03-06 | 2008-09-11 | Semler Eric J | Cancellous construct with support ring for repair of osteochondral defects |
| US7837740B2 (en) | 2007-01-24 | 2010-11-23 | Musculoskeletal Transplant Foundation | Two piece cancellous construct for cartilage repair |
| DE102005034420A1 (de) * | 2004-12-23 | 2006-07-06 | Ossacur Ag | Gelartiges Material zur Füllung von Knochen- und/oder Knorpeldefekten |
| WO2006099137A1 (en) * | 2005-03-10 | 2006-09-21 | Uab Research Foundation | Endothelial predecessor cell seeded wound healing scaffold |
| KR100702250B1 (ko) * | 2005-06-13 | 2007-04-03 | 세원셀론텍(주) | 피브린 혼합형 골절 유합용 반고형성 뼈세포 조성물 및이의 제조방법 |
| KR100751690B1 (ko) * | 2005-06-13 | 2007-08-23 | 세원셀론텍(주) | 조골 세포와 생체 기질 성분의 혼합물을 이용한 골 생성용조성물 및 그 제조방법 |
| US7897167B2 (en) | 2005-06-21 | 2011-03-01 | Cook Incorporated | Implantable graft to close a fistula |
| US7815926B2 (en) * | 2005-07-11 | 2010-10-19 | Musculoskeletal Transplant Foundation | Implant for articular cartilage repair |
| KR100774089B1 (ko) * | 2005-07-20 | 2007-11-06 | 세원셀론텍(주) | 주입형 연골세포치료제의 이식방법 |
| JP5292533B2 (ja) | 2005-08-26 | 2013-09-18 | ジンマー・インコーポレイテッド | インプラントおよび関節疾患の治療、置換および治療方法 |
| CA2623106C (en) | 2005-09-19 | 2013-12-24 | Histogenics Corporation | Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof |
| US9427423B2 (en) | 2009-03-10 | 2016-08-30 | Atrium Medical Corporation | Fatty-acid based particles |
| US9278161B2 (en) | 2005-09-28 | 2016-03-08 | Atrium Medical Corporation | Tissue-separating fatty acid adhesion barrier |
| DK1948259T3 (en) | 2005-10-26 | 2017-04-10 | Genesis Tech Ltd | ACELLULAR BIOabsorbable Tissue Regeneration Matrices Produced by Incubation of ACELLULAR BLOOD PRODUCTS |
| FR2894127B1 (fr) * | 2005-12-07 | 2008-08-22 | Alain Tornier | Dispositif de stabilisation laterale du rachis |
| ES2528272T3 (es) * | 2005-12-07 | 2015-02-06 | Isto Technologies Inc. | Métodos de reparación de cartílago |
| US8252333B2 (en) * | 2006-01-26 | 2012-08-28 | Jorge Cueto-Garcia | Biodegradable, non-toxic biological adhesive for use in abdominal surgery |
| DE102006011211A1 (de) * | 2006-03-02 | 2007-09-06 | Ossacur Ag | Material zur Behandlung von Knochen- und/oder Knorpeldefekten |
| WO2007134005A1 (en) * | 2006-05-15 | 2007-11-22 | Mayo Foundation For Medical Education And Research | Devices and methods to treat nasal passages |
| US8580307B2 (en) | 2006-06-22 | 2013-11-12 | Ethicon, Inc. | High glass transition temperature absorbable microspheres |
| JP4821466B2 (ja) * | 2006-07-03 | 2011-11-24 | 富士ゼロックス株式会社 | 液滴吐出ヘッド |
| US20080102097A1 (en) * | 2006-10-31 | 2008-05-01 | Zanella John M | Device and method for treating osteolysis using a drug depot to deliver an anti-inflammatory agent |
| CN101854960B (zh) | 2006-12-15 | 2014-06-25 | 生命连结有限公司 | 明胶-转谷氨酰胺酶止血敷料和密封材料 |
| US8163549B2 (en) * | 2006-12-20 | 2012-04-24 | Zimmer Orthobiologics, Inc. | Method of obtaining viable small tissue particles and use for tissue repair |
| US7776840B2 (en) | 2007-02-21 | 2010-08-17 | Cutanea Life Sciences, Inc. | Methods of use of biomaterial and injectable implant containing biomaterial |
| GB2447019A (en) | 2007-02-27 | 2008-09-03 | Apatech Ltd | Bone-replacement material |
| US8435551B2 (en) * | 2007-03-06 | 2013-05-07 | Musculoskeletal Transplant Foundation | Cancellous construct with support ring for repair of osteochondral defects |
| CN101854886B (zh) | 2007-03-15 | 2014-12-24 | 矫正-空位有限公司 | 假体装置及其使用方法 |
| ES2304321B1 (es) * | 2007-03-29 | 2009-09-11 | Mba Incorporado, S.A. | Procedimiento de obtencion de estructuras tridimensionales para ingenieria tisular. |
| AU2008240191B2 (en) * | 2007-04-12 | 2013-09-19 | Zimmer, Inc. | Compositions and methods for tissue repair |
| WO2008128304A1 (en) * | 2007-04-24 | 2008-10-30 | The University Of Western Australia | Tenocyte containing bioscaffolds and treatment using the same |
| DE602007010434D1 (de) * | 2007-06-01 | 2010-12-23 | Allergan Inc | Gerät zur Erzeugung des zugspannungsinduzierten Wachstums von biologischem Gewebe |
| US20080311219A1 (en) * | 2007-06-15 | 2008-12-18 | Anna Gosiewska | Tissue Fragment Compositions for the Treatment of Incontinence |
| EP2200931B1 (en) * | 2007-09-19 | 2017-06-07 | The Charles Stark Draper Laboratory, Inc. | Microfluidic structures with circular cross-section |
| WO2009042768A1 (en) * | 2007-09-25 | 2009-04-02 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Triggerably dissolvable hollow fibers for controlled delivery |
| US8697044B2 (en) | 2007-10-09 | 2014-04-15 | Allergan, Inc. | Crossed-linked hyaluronic acid and collagen and uses thereof |
| US20110020291A1 (en) * | 2007-11-17 | 2011-01-27 | Debrabrata Banerjee | Use of stem cells for wound healing |
| EP2224884A2 (en) * | 2007-12-05 | 2010-09-08 | Musculoskeletal Transplant Foundation | Cancellous bone implant for cartilage repair |
| US20090181104A1 (en) * | 2007-12-14 | 2009-07-16 | Gino Rigotti | Breast reconstruction or augmentation using computer-modeled deposition of processed adipose tissue |
| US20090234332A1 (en) * | 2008-03-17 | 2009-09-17 | The Charles Stark Draper Laboratory, Inc | Artificial microvascular device and methods for manufacturing and using the same |
| EP2487206A3 (en) | 2008-06-18 | 2012-11-28 | Lifebond Ltd | Cross-linkable gelatin-based compositions |
| WO2010003104A2 (en) * | 2008-07-02 | 2010-01-07 | Allergan, Inc. | Compositions and methods for tissue filling and regeneration |
| ES2658609T3 (es) | 2008-09-02 | 2018-03-12 | Tautona Group Lp | Hilos de ácido hialurónico y/o derivados de los mismos, métodos para fabricar los mismos, y usos de los mismos |
| US9642658B2 (en) * | 2008-10-15 | 2017-05-09 | Orthoclip Llc | Device and method for delivery of therapeutic agents via internal implants |
| WO2010045487A1 (en) * | 2008-10-15 | 2010-04-22 | Palmetto Biomedical, Inc. | Device and method for delivery of therapeutic agents via internal implants |
| WO2010053918A1 (en) * | 2008-11-05 | 2010-05-14 | Hancock Jaffe Laboratories, Inc. | Composite containing collagen and elastin as a dermal expander and tissue filler |
| US9192695B2 (en) | 2008-11-20 | 2015-11-24 | Allosource | Allografts combined with tissue derived stem cells for bone healing |
| RU2514896C2 (ru) | 2008-12-02 | 2014-05-10 | Аллерган, Инк. | Устройство для инъекций |
| US9308070B2 (en) | 2008-12-15 | 2016-04-12 | Allergan, Inc. | Pliable silk medical device |
| US20100274362A1 (en) * | 2009-01-15 | 2010-10-28 | Avner Yayon | Cartilage particle tissue mixtures optionally combined with a cancellous construct |
| US9393267B2 (en) * | 2009-02-19 | 2016-07-19 | University Of Southern California | Gel delivery system for tissue repair |
| US20120059399A1 (en) * | 2009-03-10 | 2012-03-08 | The John Hopkins University | Biological tissue connection and repair devices and methods of using same |
| US8241298B2 (en) | 2009-03-27 | 2012-08-14 | Depuy Mitek, Inc. | Methods and devices for delivering and affixing tissue scaffolds |
| US20100249924A1 (en) * | 2009-03-27 | 2010-09-30 | Allergan, Inc. | Bioerodible matrix for tissue involvement |
| US8308814B2 (en) | 2009-03-27 | 2012-11-13 | Depuy Mitek, Inc. | Methods and devices for preparing and implanting tissue scaffolds |
| US20110052695A1 (en) * | 2009-04-20 | 2011-03-03 | Allergan, Inc. | Drug delivery platforms comprising silk fibroin hydrogels and uses thereof |
| US20110189292A1 (en) * | 2009-04-20 | 2011-08-04 | Allergan, Inc. | Dermal fillers comprising silk fibroin hydrogels and uses thereof |
| EP2421551B2 (en) * | 2009-04-20 | 2020-07-15 | Allergan, Inc. | Silk fibroin hydrogels and uses thereof |
| US20110111031A1 (en) * | 2009-04-20 | 2011-05-12 | Guang-Liang Jiang | Drug Delivery Platforms Comprising Silk Fibroin Hydrogels and Uses Thereof |
| DE102009021003A1 (de) * | 2009-05-12 | 2010-11-18 | Centrotherm Sitec Gmbh | Verfahren und Vorrichtung zur Bereitstellung flüssigen Siliziums |
| US20110038910A1 (en) | 2009-08-11 | 2011-02-17 | Atrium Medical Corporation | Anti-infective antimicrobial-containing biomaterials |
| US8377432B2 (en) * | 2009-09-02 | 2013-02-19 | Khay-Yong Saw | Method and composition for neochondrogenesis |
| US20110082563A1 (en) * | 2009-10-05 | 2011-04-07 | The Charles Stark Draper Laboratory, Inc. | Microscale multiple-fluid-stream bioreactor for cell culture |
| WO2011044116A2 (en) * | 2009-10-05 | 2011-04-14 | The Charles Stark Draper Laboratory, Inc. | Three-dimensional microfluidic platforms and methods of use and manufacture thereof |
| US20140286911A1 (en) | 2013-03-15 | 2014-09-25 | Allosource | Cell repopulated collagen matrix for soft tissue repair and regeneration |
| WO2011075676A2 (en) | 2009-12-18 | 2011-06-23 | Knowlton Edward W | A skin treatment and drug delivery device |
| US9066991B2 (en) | 2009-12-22 | 2015-06-30 | Lifebond Ltd. | Modification of enzymatic crosslinkers for controlling properties of crosslinked matrices |
| US9925140B2 (en) | 2009-12-22 | 2018-03-27 | National Cheng Kung University | Cell tissue gel containing collagen and hyaluronan |
| EP2515867B1 (en) * | 2009-12-22 | 2018-08-08 | National Cheng Kung University | Cell tissue gel containing collagen and hyaluronan |
| US20110172180A1 (en) | 2010-01-13 | 2011-07-14 | Allergan Industrie. Sas | Heat stable hyaluronic acid compositions for dermatological use |
| US8337415B2 (en) * | 2010-02-22 | 2012-12-25 | Devicor Medical Products, Inc. | Tissue harvesting, mincing, and transport device |
| EP3078388B1 (en) | 2010-03-22 | 2019-02-20 | Allergan, Inc. | Cross-linked hydrogels for soft tissue augmentation |
| US20120100110A1 (en) * | 2010-04-20 | 2012-04-26 | International Stem Cell Corporation | Physiological methods for isolation of high purity cell populations |
| US8974400B2 (en) | 2010-05-11 | 2015-03-10 | Ethicon Endo-Surgery, Inc. | Instrument for applying therapeutic cells, with distal portion for processing therapeutic cells |
| US8641641B2 (en) | 2010-05-11 | 2014-02-04 | Ethicon Endo-Surgery, Inc. | Instrument for applying therapeutic cells, with proximal portion for processing therapeutic cells |
| US8349255B2 (en) | 2010-05-11 | 2013-01-08 | Ethicon Endo-Surgery, Inc. | Tissue processing system and method |
| US8286899B2 (en) | 2010-05-11 | 2012-10-16 | Ethicon Endo-Surgery, Inc. | Tissue dicing and particle separation device |
| US8464925B2 (en) | 2010-05-11 | 2013-06-18 | Ethicon Endo-Surgery, Inc. | Methods and apparatus for delivering tissue treatment compositions to stapled tissue |
| US9138210B2 (en) | 2010-05-11 | 2015-09-22 | Ethicon Endo-Surgery, Inc. | Fistula cleaning and repair device and method |
| US8646674B2 (en) | 2010-05-11 | 2014-02-11 | Ethicon Endo-Surgery, Inc. | Methods and apparatus for delivering tissue treatment compositions to stapled tissue |
| US8535239B2 (en) | 2010-05-11 | 2013-09-17 | Ethicon Endo-Surgery, Inc. | Tissue harvesting device with manual dicing mechanism |
| US20110282368A1 (en) | 2010-05-12 | 2011-11-17 | Swayze Jeffrey S | Fistula Repair Device with Extendable Barbs and Therapeutic Cell Delivery |
| US8858546B2 (en) | 2010-05-12 | 2014-10-14 | Ethicon Endo-Surgery, Inc. | Instrument for debriding fistula and applying therapeutic cells |
| US8468891B2 (en) | 2010-05-12 | 2013-06-25 | Ethicon Endo-Surgery, Inc. | Tissue processing device with ultrasonic measuring chamber |
| US8986331B2 (en) | 2010-05-12 | 2015-03-24 | Ethicon Endo-Surgery, Inc. | Instrument for debriding fistula and applying therapeutic cells |
| US8714360B2 (en) | 2010-05-12 | 2014-05-06 | Ethicon Endo-Surgery, Inc. | Tissue processing device with ultrasonic tissue particle separator |
| US8702644B2 (en) | 2010-05-13 | 2014-04-22 | Ethicon Endo-Surgery, Inc. | Instrument for debriding tissue and applying therapeutic cells |
| US8491497B2 (en) | 2010-05-13 | 2013-07-23 | Ethicon Endo-Surgery, Inc. | Method and apparatus for morcellating tissue |
| US8486155B2 (en) | 2010-05-13 | 2013-07-16 | Ethicon Endo-Surgery, Inc. | Fistula repair plug having multiple layers |
| US8568446B2 (en) | 2010-05-13 | 2013-10-29 | Ethicon Endo-Surgery, Inc. | Multi-chamber therapeutic cell applicator instrument |
| US8491526B2 (en) | 2010-05-13 | 2013-07-23 | Ethicon Endo-Surgery, Inc. | Therapeutic cell applicator instrument with modular tips |
| US8883210B1 (en) | 2010-05-14 | 2014-11-11 | Musculoskeletal Transplant Foundation | Tissue-derived tissuegenic implants, and methods of fabricating and using same |
| US9352003B1 (en) | 2010-05-14 | 2016-05-31 | Musculoskeletal Transplant Foundation | Tissue-derived tissuegenic implants, and methods of fabricating and using same |
| US10130736B1 (en) | 2010-05-14 | 2018-11-20 | Musculoskeletal Transplant Foundation | Tissue-derived tissuegenic implants, and methods of fabricating and using same |
| USD644330S1 (en) * | 2010-06-14 | 2011-08-30 | Ethicon, Inc. | Tissue repair implant |
| AU2011279250B2 (en) | 2010-07-12 | 2014-12-04 | California Institute Of Technology | Biocompatible substrate for facilitating interconnections between stem cells and target tissues and methods for implanting same |
| WO2012009707A2 (en) | 2010-07-16 | 2012-01-19 | Atrium Medical Corporation | Composition and methods for altering the rate of hydrolysis of cured oil-based materials |
| US8883139B2 (en) | 2010-08-19 | 2014-11-11 | Allergan Inc. | Compositions and soft tissue replacement methods |
| US8926963B2 (en) | 2010-08-19 | 2015-01-06 | Allergan, Inc. | Compositions and soft tissue replacement methods |
| US8697057B2 (en) | 2010-08-19 | 2014-04-15 | Allergan, Inc. | Compositions and soft tissue replacement methods |
| US8889123B2 (en) | 2010-08-19 | 2014-11-18 | Allergan, Inc. | Compositions and soft tissue replacement methods |
| US8697056B2 (en) | 2010-08-19 | 2014-04-15 | Allergan, Inc. | Compositions and soft tissue replacement methods |
| US9005605B2 (en) | 2010-08-19 | 2015-04-14 | Allergan, Inc. | Compositions and soft tissue replacement methods |
| US8741281B2 (en) | 2010-08-19 | 2014-06-03 | Allergan, Inc. | Compositions and soft tissue replacement methods |
| US8900571B2 (en) | 2010-08-19 | 2014-12-02 | Allergan, Inc. | Compositions and soft tissue replacement methods |
| US8894992B2 (en) | 2010-08-19 | 2014-11-25 | Allergan, Inc. | Compositions and soft tissue replacement methods |
| US9555171B2 (en) | 2010-09-30 | 2017-01-31 | Depuy Mitek, Llc | Methods and devices for collecting separate components of whole blood |
| US10702684B2 (en) | 2010-12-17 | 2020-07-07 | Srgi Holdings, Llc | Systems, devices and methods for fractional resection, fractional skin grafting, fractional scar reduction and fractional tattoo removal |
| US10967162B2 (en) | 2010-12-17 | 2021-04-06 | Srgi Holdings, Llc | Systems, devices and methods for fractional resection, fractional skin grafting, fractional scar reduction and fractional tattoo removal |
| US11109887B2 (en) | 2013-12-06 | 2021-09-07 | Srgi Holdings, Llc | Pixel array medical systems, devices and methods |
| US11103275B2 (en) | 2010-12-17 | 2021-08-31 | Srgi Holdings, Llc | Pixel array medical systems, devices and methods |
| US11000310B2 (en) | 2010-12-17 | 2021-05-11 | Srgi Holdings, Llc | Pixel array medical systems, devices and methods |
| US11278309B2 (en) | 2010-12-17 | 2022-03-22 | Srgi Holdings, Llc | Pixel array medical systems, devices and methods |
| US10736653B2 (en) | 2013-12-06 | 2020-08-11 | Srgi Holdings, Llc | Pixel array medical systems, devices and methods |
| NZ612801A (en) | 2010-12-27 | 2014-12-24 | Intellicell Biosciences Inc | Ultrasonic cavitation derived stromal or mesenchymal vascular extracts and cells derived therefrom obtained from adipose tissue and use thereof |
| US10478206B2 (en) | 2011-04-29 | 2019-11-19 | University Of Southern California | Instruments and methods for the implantation of cell-seeded substrates |
| US8877489B2 (en) | 2011-12-05 | 2014-11-04 | California Institute Of Technology | Ultrathin parylene-C semipermeable membranes for biomedical applications |
| US8834928B1 (en) | 2011-05-16 | 2014-09-16 | Musculoskeletal Transplant Foundation | Tissue-derived tissugenic implants, and methods of fabricating and using same |
| US9408797B2 (en) | 2011-06-03 | 2016-08-09 | Allergan, Inc. | Dermal filler compositions for fine line treatment |
| US9393263B2 (en) | 2011-06-03 | 2016-07-19 | Allergan, Inc. | Dermal filler compositions including antioxidants |
| US20130096081A1 (en) | 2011-06-03 | 2013-04-18 | Allergan, Inc. | Dermal filler compositions |
| KR102238406B1 (ko) | 2011-06-03 | 2021-04-08 | 알러간 인더스트리 에스에이에스 | 항산화제를 포함하는 피부 충전제 조성물 |
| US20130244943A1 (en) | 2011-09-06 | 2013-09-19 | Allergan, Inc. | Hyaluronic acid-collagen matrices for dermal filling and volumizing applications |
| US9662422B2 (en) | 2011-09-06 | 2017-05-30 | Allergan, Inc. | Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation |
| WO2013057566A2 (en) | 2011-10-18 | 2013-04-25 | Ortho-Space Ltd. | Prosthetic devices and methods for using same |
| US8920511B2 (en) | 2011-11-17 | 2014-12-30 | Allosource | Multi-piece machine graft systems and methods |
| US9248013B2 (en) | 2011-12-05 | 2016-02-02 | California Institute Of Technology | 3-Dimensional parylene scaffold cage |
| US9162011B2 (en) | 2011-12-19 | 2015-10-20 | Allosource | Flowable matrix compositions and methods |
| AU2013207444B2 (en) * | 2012-01-06 | 2017-08-24 | Atrium Medical Corporation | Implantable prosthesis |
| KR101347134B1 (ko) | 2012-01-31 | 2014-01-16 | 한경대학교 산학협력단 | 줄기세포 분화 또는 증식을 위한 자기장의 방향성 국소화 및 방향성 제어 장치 |
| JP5186050B1 (ja) * | 2012-02-24 | 2013-04-17 | 謙輔 山川 | 皮下組織および皮下脂肪組織増加促進用組成物 |
| WO2013163358A1 (en) | 2012-04-24 | 2013-10-31 | Harvard Bioscience, Inc. | Engineered tissue scaffolds and supports therefor |
| US9867880B2 (en) | 2012-06-13 | 2018-01-16 | Atrium Medical Corporation | Cured oil-hydrogel biomaterial compositions for controlled drug delivery |
| US10154881B2 (en) * | 2012-08-10 | 2018-12-18 | Arizona Board Of Regents For And On Behalf Of Arizona State University | Methods and compositions for tissue adhesives |
| WO2014028463A1 (en) * | 2012-08-14 | 2014-02-20 | Allergan, Inc. | Syringe for mixing and dispensing adipose tissue |
| CA2891272C (en) | 2012-11-15 | 2022-11-22 | Allosource | Minced cartilage systems and methods |
| US10245306B2 (en) | 2012-11-16 | 2019-04-02 | Isto Technologies Ii, Llc | Flexible tissue matrix and methods for joint repair |
| US20140178343A1 (en) | 2012-12-21 | 2014-06-26 | Jian Q. Yao | Supports and methods for promoting integration of cartilage tissue explants |
| EP2943231A4 (en) | 2013-01-09 | 2016-12-07 | Harvard Apparatus Regenerative Tech Inc | SYNTHETIC SCAFFOLD |
| DK2956543T3 (da) | 2013-02-12 | 2019-01-02 | Replicel Life Sciences Inc | Sammensætninger og fremgangsmåder til behandling og reparation af sener |
| AU2014218734B2 (en) | 2013-02-22 | 2018-03-15 | Allosource | Cartilage mosaic compositions and methods |
| CA2897855A1 (en) | 2013-03-07 | 2014-09-12 | Allosource | Consistent calcium content bone allograft systems and methods |
| US9867939B2 (en) | 2013-03-12 | 2018-01-16 | Allergan, Inc. | Adipose tissue combinations, devices, and uses thereof |
| WO2014151939A1 (en) * | 2013-03-15 | 2014-09-25 | Allosource | Perforated osteochondral allograft compositions |
| US20140350516A1 (en) | 2013-05-23 | 2014-11-27 | Allergan, Inc. | Mechanical syringe accessory |
| US20140350518A1 (en) | 2013-05-23 | 2014-11-27 | Allergan, Inc. | Syringe extrusion accessory |
| US9078862B2 (en) | 2013-06-06 | 2015-07-14 | General Electric Company | Platelet activation using long electric field pulses |
| US9238808B2 (en) | 2013-06-06 | 2016-01-19 | General Electric Company | Modular adjustable pulse generator |
| MX2016001247A (es) | 2013-07-30 | 2016-08-17 | Musculoskeletal Transplant Foundation | Matrices derivadas de tejido suave acelular y metodos para preparar las mismas. |
| ES2827049T3 (es) | 2013-10-02 | 2021-05-19 | Srgi Holdings Llc | Dispositivos médicos de conjunto de píxeles |
| BR112016007476A2 (pt) | 2013-10-02 | 2017-09-12 | Srgi Holdings Llc | métodos e dispositivos médicos de conjunto de pixel |
| US9248384B2 (en) | 2013-10-02 | 2016-02-02 | Allergan, Inc. | Fat processing system |
| US11229452B2 (en) | 2013-12-06 | 2022-01-25 | Srgi Holdings, Llc | Pixel array medical systems, devices and methods |
| US11937846B2 (en) | 2013-12-06 | 2024-03-26 | Srgi Holdings Llc | Pixel array medical systems, devices and methods |
| TW201538730A (zh) | 2014-02-12 | 2015-10-16 | Replicel Life Sciences Inc | 用於治療骨骼、關節及軟骨之組合物及方法 |
| GB2523593A (en) * | 2014-02-28 | 2015-09-02 | Adrian Robert Ford | Method, design and preparation of a biological implant with enhanced biological activity via modification of the plastic deformation characteristics |
| US10029048B2 (en) | 2014-05-13 | 2018-07-24 | Allergan, Inc. | High force injection devices |
| WO2015175983A1 (en) | 2014-05-16 | 2015-11-19 | Allosource | Composite bone constructs and methods |
| EP3200838B1 (en) | 2014-09-30 | 2019-09-18 | Allergan Industrie, SAS | Stable hydrogel compositions including additives |
| US10226585B2 (en) | 2014-10-01 | 2019-03-12 | Allergan, Inc. | Devices for injection and dosing |
| EP3579767B1 (en) | 2014-10-02 | 2025-10-08 | SRGI Holdings, LLC | Pixel array medical systems and devices |
| US10179191B2 (en) | 2014-10-09 | 2019-01-15 | Isto Technologies Ii, Llc | Flexible tissue matrix and methods for joint repair |
| MX2017004520A (es) | 2014-10-14 | 2018-03-15 | Lynch Samuel | Composiciones para tratar heridas. |
| US10077420B2 (en) | 2014-12-02 | 2018-09-18 | Histogenics Corporation | Cell and tissue culture container |
| US9238090B1 (en) | 2014-12-24 | 2016-01-19 | Fettech, Llc | Tissue-based compositions |
| EP3253308A4 (en) | 2015-02-05 | 2018-10-24 | SRGI Holdings LLC | Pixel array medical systems, devices and methods |
| HUE047971T2 (hu) | 2015-02-13 | 2020-05-28 | Allergan Ind Sas | Az arcelemek - például az áll - formázására, megnagyobbítására vagy korrekciójára szolgáló implantátumok |
| AU2016229013B2 (en) | 2015-03-10 | 2020-05-21 | Allergan Sales, Llc | Multiple needle injector |
| CA3177726A1 (en) | 2015-05-21 | 2016-11-24 | Musculoskeletal Transplant Foundation | Modified demineralized cortical bone fibers |
| US10912864B2 (en) | 2015-07-24 | 2021-02-09 | Musculoskeletal Transplant Foundation | Acellular soft tissue-derived matrices and methods for preparing same |
| US11052175B2 (en) | 2015-08-19 | 2021-07-06 | Musculoskeletal Transplant Foundation | Cartilage-derived implants and methods of making and using same |
| US11490952B2 (en) | 2015-08-31 | 2022-11-08 | Srgi Holdings, Llc | Pixel array medical devices and methods |
| US11751903B2 (en) | 2015-08-31 | 2023-09-12 | Srgi Holdings, Llc | Pixel array medical systems, devices and methods |
| US11980389B2 (en) | 2015-08-31 | 2024-05-14 | Srgi Holdings Llc | Handed spiral slotted scalpet array |
| US10959761B2 (en) | 2015-09-18 | 2021-03-30 | Ortho-Space Ltd. | Intramedullary fixated subacromial spacers |
| US11564706B2 (en) | 2019-10-28 | 2023-01-31 | Srgi Holdings, Llc | Pixel array medical systems, devices and methods |
| WO2017146627A1 (en) * | 2016-02-26 | 2017-08-31 | Neuronano Ab | Method of implantation of cell aggregates and tissue fragments |
| RU2725968C2 (ru) | 2016-04-08 | 2020-07-07 | Аллерган, Инк. | Аспирационно-инъекционное устройство |
| WO2017192723A1 (en) * | 2016-05-03 | 2017-11-09 | Srgi Holdings, Llc | Pixel array medical systems, devices and methods |
| IT201600098385A1 (it) * | 2016-09-30 | 2018-03-30 | Antonio Sambusseti | Prodotto per la ricostruzione della cartilagine |
| US11045981B2 (en) | 2017-01-30 | 2021-06-29 | Ortho-Space Ltd. | Processing machine and methods for processing dip-molded articles |
| USD867582S1 (en) | 2017-03-24 | 2019-11-19 | Allergan, Inc. | Syringe device |
| WO2018217479A2 (en) | 2017-05-11 | 2018-11-29 | Srgi Holdings, Llc | Systems, devices and methods for fractional resection, fractional skin grafting, fractional scar reduction and fractional tattoo removal |
| MY199324A (en) * | 2017-05-30 | 2023-10-24 | Aqpha Ip B V | Resorbable biodegradable medical and cosmetic composition comprising poly(1,3-trimethylene carbonate) |
| WO2019006328A1 (en) | 2017-06-30 | 2019-01-03 | Allosource | CELL BONE GRAFTS, AND METHODS OF MAKING AND USING |
| EP3787702B1 (en) | 2018-05-03 | 2024-08-07 | CollPlant Ltd. | Dermal fillers and applications thereof |
| US11998654B2 (en) | 2018-07-12 | 2024-06-04 | Bard Shannon Limited | Securing implants and medical devices |
| US11674131B2 (en) | 2018-12-03 | 2023-06-13 | Ross Ward | Indirect ultrasonic cavitation-derived perivascular cells and methods of use thereof |
| CN111671974A (zh) * | 2020-04-26 | 2020-09-18 | 上海亚朋生物技术有限公司 | 一种吸水诱导形状记忆性的脱细胞真皮基质组织填充物及其制备方法 |
| DE102020124372A1 (de) * | 2020-09-18 | 2022-03-24 | Carl Zeiss Meditec Ag | Gewebekleber zur Anwendung in einem Behandlungsverfahren, bei welchem einem menschlichen oder tierischen Patienten ein ophthalmologisches Implantat implantiert wird, und ophthalmologisches Implantationssystem |
Family Cites Families (275)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US259260A (en) | 1882-06-06 | Adolf baeyer | ||
| US224226A (en) | 1880-02-03 | Frank rhind | ||
| US206200A (en) | 1878-07-23 | Improvement in fountain-pen holders | ||
| GB1008193A (en) | 1961-03-01 | 1965-10-27 | Ethicon Inc | Improvements in or relating to surgical implants |
| US3272204A (en) | 1965-09-22 | 1966-09-13 | Ethicon Inc | Absorbable collagen prosthetic implant with non-absorbable reinforcing strands |
| US3857932A (en) | 1970-09-09 | 1974-12-31 | F Gould | Dry hydrophilic acrylate or methacrylate polymer prolonged release drug implants |
| US3739402A (en) | 1970-10-15 | 1973-06-19 | Cutter Lab | Bicuspid fascia lata valve |
| US3812017A (en) | 1972-07-26 | 1974-05-21 | Kennecott Copper Corp | Desulfurized char with phosphoric acid |
| US4045418A (en) | 1975-01-28 | 1977-08-30 | Gulf Oil Corporation | Copolymers of D,L-lactide and epsilon caprolactone |
| US4057537A (en) | 1975-01-28 | 1977-11-08 | Gulf Oil Corporation | Copolymers of L-(-)-lactide and epsilon caprolactone |
| US4130689A (en) | 1976-06-11 | 1978-12-19 | International Paper Company | Production of high strength hollow rayon fibers |
| US4141087A (en) | 1977-01-19 | 1979-02-27 | Ethicon, Inc. | Isomorphic copolyoxalates and sutures thereof |
| US4208511A (en) | 1977-01-19 | 1980-06-17 | Ethicon, Inc. | Isomorphic copolyoxalates and sutures thereof |
| US4105034A (en) | 1977-06-10 | 1978-08-08 | Ethicon, Inc. | Poly(alkylene oxalate) absorbable coating for sutures |
| US4140678A (en) | 1977-06-13 | 1979-02-20 | Ethicon, Inc. | Synthetic absorbable surgical devices of poly(alkylene oxalates) |
| US4205399A (en) | 1977-06-13 | 1980-06-03 | Ethicon, Inc. | Synthetic absorbable surgical devices of poly(alkylene oxalates) |
| US4130639A (en) | 1977-09-28 | 1978-12-19 | Ethicon, Inc. | Absorbable pharmaceutical compositions based on isomorphic copolyoxalates |
| US4344193A (en) | 1980-11-28 | 1982-08-17 | Kenny Charles H | Meniscus prosthesis |
| US4553272A (en) | 1981-02-26 | 1985-11-19 | University Of Pittsburgh | Regeneration of living tissues by growth of isolated cells in porous implant and product thereof |
| US4520821A (en) | 1982-04-30 | 1985-06-04 | The Regents Of The University Of California | Growing of long-term biological tissue correction structures in vivo |
| US4801299A (en) | 1983-06-10 | 1989-01-31 | University Patents, Inc. | Body implants of extracellular matrix and means and methods of making and using such implants |
| GB2151487A (en) | 1983-12-15 | 1985-07-24 | Showell A W | Replacements for ligaments and tendons |
| US4609551A (en) | 1984-03-20 | 1986-09-02 | Arnold Caplan | Process of and material for stimulating growth of cartilage and bony tissue at anatomical sites |
| US4837285A (en) | 1984-03-27 | 1989-06-06 | Medimatrix | Collagen matrix beads for soft tissue repair |
| NL8402178A (nl) | 1984-07-10 | 1986-02-03 | Rijksuniversiteit | Entstuk, geschikt voor behandeling door reconstructieve chirurgie van beschadigingen van beenachtig materiaal. |
| US4597766A (en) | 1984-10-26 | 1986-07-01 | American Hospital Supply Corporation | Implantable bioprosthetic tendons and ligaments |
| CH665768A5 (de) | 1985-05-03 | 1988-06-15 | Sulzer Ag | Kuenstliches band aus textilen schlauchgebilden. |
| US5061281A (en) | 1985-12-17 | 1991-10-29 | Allied-Signal Inc. | Bioresorbable polymers and implantation devices thereof |
| US6005161A (en) | 1986-01-28 | 1999-12-21 | Thm Biomedical, Inc. | Method and device for reconstruction of articular cartilage |
| US5904717A (en) | 1986-01-28 | 1999-05-18 | Thm Biomedical, Inc. | Method and device for reconstruction of articular cartilage |
| US5902741A (en) | 1986-04-18 | 1999-05-11 | Advanced Tissue Sciences, Inc. | Three-dimensional cartilage cultures |
| US5266480A (en) | 1986-04-18 | 1993-11-30 | Advanced Tissue Sciences, Inc. | Three-dimensional skin culture system |
| US5863531A (en) | 1986-04-18 | 1999-01-26 | Advanced Tissue Sciences, Inc. | In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework |
| US5736372A (en) | 1986-11-20 | 1998-04-07 | Massachusetts Institute Of Technology | Biodegradable synthetic polymeric fibrous matrix containing chondrocyte for in vivo production of a cartilaginous structure |
| US5041138A (en) | 1986-11-20 | 1991-08-20 | Massachusetts Institute Of Technology | Neomorphogenesis of cartilage in vivo from cell culture |
| DE3644588C1 (de) | 1986-12-27 | 1988-03-10 | Ethicon Gmbh | Implantat und Verfahren zu seiner Herstellung |
| NL8700113A (nl) | 1987-01-19 | 1988-08-16 | Groningen Science Park | Entstuk, geschikt voor behandeling door reconstructieve chirurgie, met weefsel specifieke porositeit, alsmede werkwijze ter vervaardiging van het entstuk. |
| US5425766A (en) | 1987-03-09 | 1995-06-20 | Astra Tech Aktiebolag | Resorbable prosthesis |
| US5306311A (en) | 1987-07-20 | 1994-04-26 | Regen Corporation | Prosthetic articular cartilage |
| US5007934A (en) | 1987-07-20 | 1991-04-16 | Regen Corporation | Prosthetic meniscus |
| US5681353A (en) | 1987-07-20 | 1997-10-28 | Regen Biologics, Inc. | Meniscal augmentation device |
| US5263984A (en) | 1987-07-20 | 1993-11-23 | Regen Biologics, Inc. | Prosthetic ligaments |
| US5078744A (en) | 1987-09-04 | 1992-01-07 | Bio-Products, Inc. | Method of using tendon/ligament substitutes composed of long, parallel, non-antigenic tendon/ligament fibers |
| SU1535542A1 (ru) | 1987-11-18 | 1990-01-15 | Всесоюзный Научно-Исследовательский Институт Глазных Болезней | Способ лечени вторичной глаукомы |
| GB8803697D0 (en) | 1988-02-17 | 1988-03-16 | Deltanine Research Ltd | Clinical developments using amniotic membrane cells |
| US5053050A (en) | 1988-04-29 | 1991-10-01 | Samuel Itay | Compositions for repair of cartilage and bone |
| US4902508A (en) | 1988-07-11 | 1990-02-20 | Purdue Research Foundation | Tissue graft composition |
| US4917700A (en) | 1988-08-01 | 1990-04-17 | Zimmer, Inc. | Prosthetic ligament |
| US4938763B1 (en) | 1988-10-03 | 1995-07-04 | Atrix Lab Inc | Biodegradable in-situ forming implants and method of producing the same |
| JPH02143945A (ja) | 1988-11-26 | 1990-06-01 | Seiko Epson Corp | 磁気ヘッド装置 |
| US5258028A (en) | 1988-12-12 | 1993-11-02 | Ersek Robert A | Textured micro implants |
| US5147400A (en) | 1989-05-10 | 1992-09-15 | United States Surgical Corporation | Connective tissue prosthesis |
| US5487897A (en) | 1989-07-24 | 1996-01-30 | Atrix Laboratories, Inc. | Biodegradable implant precursor |
| US4946377A (en) | 1989-11-06 | 1990-08-07 | W. L. Gore & Associates, Inc. | Tissue repair device |
| GB8928250D0 (en) | 1989-12-14 | 1990-02-21 | Erba Carlo Spa | Use of supercritical fluids to obtain porous sponges of biodegradable polymers |
| EP0447355A1 (de) | 1990-03-12 | 1991-09-18 | Gebrüder Sulzer Aktiengesellschaft | Implantat für den menschlichen Körper |
| US5108989A (en) | 1990-04-04 | 1992-04-28 | Genentech, Inc. | Method of predisposing mammals to accelerated tissue repair |
| US5269785A (en) | 1990-06-28 | 1993-12-14 | Bonutti Peter M | Apparatus and method for tissue removal |
| FR2667246A1 (fr) | 1990-10-02 | 1992-04-03 | Imedex | Biomateriau a base de collagene et des applications. |
| US5654135A (en) | 1990-10-02 | 1997-08-05 | Imedex, Societe Anonyme | Biomaterial based on collagen and its application |
| US6197325B1 (en) | 1990-11-27 | 2001-03-06 | The American National Red Cross | Supplemented and unsupplemented tissue sealants, methods of their production and use |
| US6054122A (en) | 1990-11-27 | 2000-04-25 | The American National Red Cross | Supplemented and unsupplemented tissue sealants, methods of their production and use |
| US5206023A (en) | 1991-01-31 | 1993-04-27 | Robert F. Shaw | Method and compositions for the treatment and repair of defects or lesions in cartilage |
| FR2679250B1 (fr) | 1991-07-19 | 1995-07-13 | Inoteb | Utilisation de carbonate de calcium poreux comme materiau support de culture in vitro de cellules eucaryotes. |
| US6773458B1 (en) | 1991-07-24 | 2004-08-10 | Baxter International Inc. | Angiogenic tissue implant systems and methods |
| FR2679778B1 (fr) | 1991-08-02 | 1995-07-07 | Coletica | Utilisation de collagene reticule par un agent de reticulation pour la fabrication d'une membrane suturable, biocompatible, a resorption lente, ainsi qu'une telle membrane. |
| US5281422A (en) | 1991-09-24 | 1994-01-25 | Purdue Research Foundation | Graft for promoting autogenous tissue growth |
| US5681572A (en) | 1991-10-18 | 1997-10-28 | Seare, Jr.; William J. | Porous material product and process |
| IT1254170B (it) | 1991-12-18 | 1995-09-11 | Mini Ricerca Scient Tecnolog | Membrane composite per la rigenerazione guidata di tessuti |
| US6537574B1 (en) | 1992-02-11 | 2003-03-25 | Bioform, Inc. | Soft tissue augmentation material |
| US5326357A (en) | 1992-03-18 | 1994-07-05 | Mount Sinai Hospital Corporation | Reconstituted cartridge tissue |
| FR2688690B1 (fr) | 1992-03-19 | 1998-04-10 | Laboureau Jacques | Ligament artificiel. |
| GB9206509D0 (en) | 1992-03-25 | 1992-05-06 | Jevco Ltd | Heteromorphic sponges containing active agents |
| US5366756A (en) | 1992-06-15 | 1994-11-22 | United States Surgical Corporation | Method for treating bioabsorbable implant material |
| US5468253A (en) | 1993-01-21 | 1995-11-21 | Ethicon, Inc. | Elastomeric medical device |
| US5514378A (en) | 1993-02-01 | 1996-05-07 | Massachusetts Institute Of Technology | Biocompatible polymer membranes and methods of preparation of three dimensional membrane structures |
| US5656492A (en) | 1993-02-12 | 1997-08-12 | Brigham And Women's Hospital, Inc. | Cell induction device |
| ATE190633T1 (de) | 1993-04-27 | 2000-04-15 | Cytotherapeutics Inc | Membran aus einem acrylnitrilpolymer |
| US5709854A (en) | 1993-04-30 | 1998-01-20 | Massachusetts Institute Of Technology | Tissue formation by injecting a cell-polymeric solution that gels in vivo |
| DE69420024T2 (de) | 1993-08-10 | 2000-02-24 | W.L. Gore & Associates, Inc. | Zelleinkapselungsvorrichtung |
| EP0713364A4 (en) | 1993-08-13 | 1996-12-27 | Shalaby W Shalaby | MICROPOROUS POLYMERIC FOAMS AND MICROTEXTURED SURFACES |
| US5455041A (en) | 1993-09-13 | 1995-10-03 | Research Foundation Of State University Of New York At Buffalo | Method for inducing periodontal tissue regeneration |
| GB2281861B (en) | 1993-09-21 | 1997-08-20 | Johnson & Johnson Medical | Bioabsorbable wound implant materials containing microspheres |
| GB2282328B (en) | 1993-09-29 | 1997-10-08 | Johnson & Johnson Medical | Absorbable structures for ligament and tendon repair |
| US5723331A (en) | 1994-05-05 | 1998-03-03 | Genzyme Corporation | Methods and compositions for the repair of articular cartilage defects in mammals |
| US5855608A (en) | 1994-05-13 | 1999-01-05 | Thm Biomedical, Inc. | Device and methods for in vivo culturing of diverse tissue cells |
| US5571189A (en) | 1994-05-20 | 1996-11-05 | Kuslich; Stephen D. | Expandable fabric implant for stabilizing the spinal motion segment |
| US5837235A (en) | 1994-07-08 | 1998-11-17 | Sulzer Medizinaltechnik Ag | Process for regenerating bone and cartilage |
| JP3705842B2 (ja) * | 1994-08-04 | 2005-10-12 | 株式会社ルネサステクノロジ | 半導体装置 |
| US5632745A (en) | 1995-02-07 | 1997-05-27 | R&D Biologicals, Inc. | Surgical implantation of cartilage repair unit |
| US5769899A (en) | 1994-08-12 | 1998-06-23 | Matrix Biotechnologies, Inc. | Cartilage repair unit |
| FR2724563A1 (fr) | 1994-09-15 | 1996-03-22 | Coletica | Utilisation de membranes collageniques comme protheses de regeneration peritoneale |
| TW369414B (en) | 1994-09-30 | 1999-09-11 | Yamanouchi Pharma Co Ltd | Bone formation transplant |
| US6110212A (en) | 1994-11-15 | 2000-08-29 | Kenton W. Gregory | Elastin and elastin-based materials |
| US5891558A (en) | 1994-11-22 | 1999-04-06 | Tissue Engineering, Inc. | Biopolymer foams for use in tissue repair and reconstruction |
| US6485723B1 (en) | 1995-02-10 | 2002-11-26 | Purdue Research Foundation | Enhanced submucosal tissue graft constructs |
| US6592588B1 (en) | 1995-02-16 | 2003-07-15 | Arthrex, Inc. | Apparatus for osteochondral autograft transplantation |
| US5919196A (en) | 1995-02-16 | 1999-07-06 | Arthrex, Inc. | Method and apparatus for osteochondral autograft transplantation |
| GB9503492D0 (en) | 1995-02-22 | 1995-04-12 | Ed Geistlich S Hne A G F R Che | Chemical product |
| US7141072B2 (en) | 1998-10-05 | 2006-11-28 | Ed. Geistlich Soehne Ag Fuer Chemische Industrie | Method for promoting regeneration of surface cartilage in a damaged joint using multi-layer covering |
| US5607687A (en) | 1995-03-06 | 1997-03-04 | Ethicon, Inc. | Polymer blends containing absorbable polyoxaesters |
| US5464929A (en) | 1995-03-06 | 1995-11-07 | Ethicon, Inc. | Absorbable polyoxaesters |
| US5618552A (en) | 1995-03-06 | 1997-04-08 | Ethicon, Inc. | Absorbable polyoxaesters |
| US5698213A (en) | 1995-03-06 | 1997-12-16 | Ethicon, Inc. | Hydrogels of absorbable polyoxaesters |
| US5700583A (en) | 1995-03-06 | 1997-12-23 | Ethicon, Inc. | Hydrogels of absorbable polyoxaesters containing amines or amido groups |
| US5597579A (en) | 1995-03-06 | 1997-01-28 | Ethicon, Inc. | Blends of absorbable polyoxaamides |
| US5648088A (en) | 1995-03-06 | 1997-07-15 | Ethicon, Inc. | Blends of absorbable polyoxaesters containing amines and/or amide groups |
| US5859150A (en) | 1995-03-06 | 1999-01-12 | Ethicon, Inc. | Prepolymers of absorbable polyoxaesters |
| US5595751A (en) | 1995-03-06 | 1997-01-21 | Ethicon, Inc. | Absorbable polyoxaesters containing amines and/or amido groups |
| US5904716A (en) | 1995-04-26 | 1999-05-18 | Gendler; El | Method for reconstituting cartilage tissue using demineralized bone and product thereof |
| US6121042A (en) | 1995-04-27 | 2000-09-19 | Advanced Tissue Sciences, Inc. | Apparatus and method for simulating in vivo conditions while seeding and culturing three-dimensional tissue constructs |
| US6123727A (en) | 1995-05-01 | 2000-09-26 | Massachusetts Institute Of Technology | Tissue engineered tendons and ligaments |
| US6027742A (en) | 1995-05-19 | 2000-02-22 | Etex Corporation | Bioresorbable ceramic composites |
| US6132463A (en) | 1995-05-19 | 2000-10-17 | Etex Corporation | Cell seeding of ceramic compositions |
| GB9510624D0 (en) | 1995-05-25 | 1995-07-19 | Ellis Dev Ltd | Textile surgical implants |
| US6096532A (en) | 1995-06-07 | 2000-08-01 | Aastrom Biosciences, Inc. | Processor apparatus for use in a system for maintaining and growing biological cells |
| FR2737663B1 (fr) | 1995-08-07 | 1997-10-03 | Centre Nat Rech Scient | Composition pour bio-materiau, procede de preparation |
| US5716413A (en) | 1995-10-11 | 1998-02-10 | Osteobiologics, Inc. | Moldable, hand-shapable biodegradable implant material |
| DE69637619D1 (de) | 1995-11-06 | 2008-09-11 | Mount Sinai Hospital Corp | Rekonstituiertes mineralisiertes knorpelgewebe |
| US6200606B1 (en) | 1996-01-16 | 2001-03-13 | Depuy Orthopaedics, Inc. | Isolation of precursor cells from hematopoietic and nonhematopoietic tissues and their use in vivo bone and cartilage regeneration |
| US5842477A (en) * | 1996-02-21 | 1998-12-01 | Advanced Tissue Sciences, Inc. | Method for repairing cartilage |
| US5788625A (en) | 1996-04-05 | 1998-08-04 | Depuy Orthopaedics, Inc. | Method of making reconstructive SIS structure for cartilaginous elements in situ |
| US5755791A (en) | 1996-04-05 | 1998-05-26 | Purdue Research Foundation | Perforated submucosal tissue graft constructs |
| ES2329953T3 (es) | 1996-04-19 | 2009-12-02 | Osiris Therapeutics, Inc. | Regeneracion e incremento de hueso utilizando celulas madre mesenquimales. |
| AU2759397A (en) | 1996-05-28 | 1998-01-05 | 1218122 Ontario Inc. | Resorbable implant biomaterial made of condensed calcium phosphate particles |
| ES2210526T3 (es) | 1996-06-04 | 2004-07-01 | Centerpulse Biologics Inc. | Procedimiento de produccion de cartilago. |
| US6666892B2 (en) | 1996-08-23 | 2003-12-23 | Cook Biotech Incorporated | Multi-formed collagenous biomaterial medical device |
| US5759190A (en) | 1996-08-30 | 1998-06-02 | Vts Holdings Limited | Method and kit for autologous transplantation |
| US6569172B2 (en) | 1996-08-30 | 2003-05-27 | Verigen Transplantation Service International (Vtsi) | Method, instruments, and kit for autologous transplantation |
| US5989269A (en) | 1996-08-30 | 1999-11-23 | Vts Holdings L.L.C. | Method, instruments and kit for autologous transplantation |
| US6120514A (en) | 1996-08-30 | 2000-09-19 | Vts Holdings, Llc | Method and kit for autologous transplantation |
| US6251673B1 (en) | 1996-09-10 | 2001-06-26 | Mediphore-Biotechnologie Ag | Method for manufacturing an implant consisting of a carrier material containing medically active agents |
| US5964805A (en) | 1997-02-12 | 1999-10-12 | Stone; Kevin R. | Method and paste for articular cartilage transplantation |
| EP0873145A2 (en) | 1996-11-15 | 1998-10-28 | Advanced Bio Surfaces, Inc. | Biomaterial system for in situ tissue repair |
| US6187053B1 (en) | 1996-11-16 | 2001-02-13 | Will Minuth | Process for producing a natural implant |
| FR2755846B1 (fr) | 1996-11-20 | 1998-12-31 | Jacques Philippe Laboureau | Ligament prothetique pre-oriente et procede de confection |
| US7618451B2 (en) | 2001-05-25 | 2009-11-17 | Conformis, Inc. | Patient selectable joint arthroplasty devices and surgical tools facilitating increased accuracy, speed and simplicity in performing total and partial joint arthroplasty |
| US5914121A (en) | 1997-02-12 | 1999-06-22 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Formation of human bone in vivo using ceramic powder and human marrow stromal fibroblasts |
| JPH10234844A (ja) | 1997-02-25 | 1998-09-08 | Gunze Ltd | 軟骨組織再生用基材及びこれを用いた軟骨組織再生法 |
| GB9704749D0 (en) | 1997-03-07 | 1997-04-23 | Univ London | Tissue Implant |
| US6001352A (en) | 1997-03-31 | 1999-12-14 | Osteobiologics, Inc. | Resurfacing cartilage defects with chondrocytes proliferated without differentiation using platelet-derived growth factor |
| GB9708692D0 (en) | 1997-04-30 | 1997-06-18 | Jahoda Colin A B | Dermal sheath tissue and/or cells derived therefrom in wound healing |
| JP4132089B2 (ja) | 1997-05-30 | 2008-08-13 | オステオバイオロジックス，インコーポレイテッド | 繊維強化多孔性生体分解性移植デバイス |
| US6042592A (en) | 1997-08-04 | 2000-03-28 | Meadox Medicals, Inc. | Thin soft tissue support mesh |
| US6110209A (en) | 1997-08-07 | 2000-08-29 | Stone; Kevin R. | Method and paste for articular cartilage transplantation |
| US6241771B1 (en) | 1997-08-13 | 2001-06-05 | Cambridge Scientific, Inc. | Resorbable interbody spinal fusion devices |
| US6511958B1 (en) | 1997-08-14 | 2003-01-28 | Sulzer Biologics, Inc. | Compositions for regeneration and repair of cartilage lesions |
| EP1018980B9 (en) | 1997-10-01 | 2004-01-07 | Boston Scientific Limited | Pelvic floor reconstruction |
| US6165217A (en) | 1997-10-02 | 2000-12-26 | Gore Enterprise Holdings, Inc. | Self-cohering, continuous filament non-woven webs |
| AU1070899A (en) | 1997-10-10 | 1999-05-03 | Corbitt, John D. Jr. | Breast implant |
| US6117166A (en) | 1997-10-27 | 2000-09-12 | Winston; Thomas R. | Apparatus and methods for grafting blood vessel tissue |
| EP1030676B1 (en) | 1997-10-30 | 2005-09-14 | The General Hospital Corporation | Bonding of cartilaginous matrices using isolated chondrocytes |
| US7456012B2 (en) | 1997-11-06 | 2008-11-25 | Cellectricon Ab | Method and apparatus for spatially confined electroporation |
| SE9704076D0 (sv) | 1997-11-06 | 1997-11-06 | Holdingbolaget Vid Goeteborgs | Method for permeabilisation of cell structures and use thereof |
| CA2309904A1 (en) | 1997-11-14 | 1999-05-27 | Cedars-Sinai Medical Center | Transfection and transfer of male germ cells for generation of transgenic species |
| US6080579A (en) | 1997-11-26 | 2000-06-27 | Charlotte-Mecklenburg Hospital Authority | Method for producing human intervertebral disc cells |
| US6197586B1 (en) | 1997-12-12 | 2001-03-06 | The Regents Of The University Of California | Chondrocyte-like cells useful for tissue engineering and methods |
| US6187329B1 (en) | 1997-12-23 | 2001-02-13 | Board Of Regents Of The University Of Texas System | Variable permeability bone implants, methods for their preparation and use |
| KR100269518B1 (ko) * | 1997-12-29 | 2000-10-16 | 구본준 | 박막트랜지스터 제조방법 |
| US6291240B1 (en) | 1998-01-29 | 2001-09-18 | Advanced Tissue Sciences, Inc. | Cells or tissues with increased protein factors and methods of making and using same |
| DE19803673A1 (de) | 1998-01-30 | 1999-08-05 | Norbert M Dr Meenen | Biohybrider Gelenkflächenersatz |
| EP1053002A1 (en) | 1998-02-10 | 2000-11-22 | Oregon Health Sciences University | Treatment of bony defects with osteoblast precursor cells |
| US6179872B1 (en) | 1998-03-17 | 2001-01-30 | Tissue Engineering | Biopolymer matt for use in tissue repair and reconstruction |
| DE19812195C2 (de) | 1998-03-19 | 2000-03-30 | Uwe Storch | Verfahren zur Herstellung eines gewebebildenden Implantats und seine Verwendung |
| US6471958B2 (en) | 1998-03-24 | 2002-10-29 | University Of North Texas Health Science Center | Non-contracting tissue equivalent |
| US6143293A (en) | 1998-03-26 | 2000-11-07 | Carnegie Mellon | Assembled scaffolds for three dimensional cell culturing and tissue generation |
| US6886568B2 (en) | 1998-04-08 | 2005-05-03 | The Johns Hopkins University | Method for fabricating cell-containing implants |
| US6378527B1 (en) | 1998-04-08 | 2002-04-30 | Chondros, Inc. | Cell-culture and polymer constructs |
| PL186960B1 (pl) | 1998-05-04 | 2004-04-30 | Adamed Sp Z Oo | Zestaw dopochwowy |
| JP4480270B2 (ja) | 1998-05-19 | 2010-06-16 | ジ・アメリカン・ナショナル・レッド・クロス | 止血サンドウィッチ包帯 |
| US20030064917A1 (en) | 1998-07-23 | 2003-04-03 | Crawford Susan E. | Methods and compositions for inhibiting angiogenesis |
| AU5390699A (en) | 1998-07-24 | 2000-02-14 | Pharmacal Biotechnologies, Inc. | Osseous tissue reconstruction system and method |
| US6605294B2 (en) | 1998-08-14 | 2003-08-12 | Incept Llc | Methods of using in situ hydration of hydrogel articles for sealing or augmentation of tissue or vessels |
| US6551355B1 (en) | 1998-08-14 | 2003-04-22 | Cambridge Scientific, Inc. | Tissue transplant coated with biocompatible biodegradable polymer |
| US6132468A (en) | 1998-09-10 | 2000-10-17 | Mansmann; Kevin A. | Arthroscopic replacement of cartilage using flexible inflatable envelopes |
| US6530956B1 (en) | 1998-09-10 | 2003-03-11 | Kevin A. Mansmann | Resorbable scaffolds to promote cartilage regeneration |
| DE19841698A1 (de) | 1998-09-11 | 2000-03-16 | Curative Technologies Gmbh | Wachstumsfaktor-enthaltende Zusammensetzung zur Heilung von Gewebeschäden |
| DE69939025D1 (de) | 1998-10-14 | 2008-08-14 | Depuy Spine Inc | Extrazelluläre, gdf-5 enthaltende matrix zur induktion oder verstärkung der chondrogenese |
| US6214055B1 (en) | 1998-10-30 | 2001-04-10 | Mures Cardiovascular Research, Inc. | Method and kit for rapid preparation of autologous tissue medical devices |
| US6727224B1 (en) | 1999-02-01 | 2004-04-27 | Genetics Institute, Llc. | Methods and compositions for healing and repair of articular cartilage |
| WO2000044413A1 (en) | 1999-02-01 | 2000-08-03 | Genetics Institute, Inc. | Methods and compositions for healing and repair of articular cartilage |
| EP1027897B1 (en) | 1999-02-10 | 2005-04-13 | IsoTis N.V. | Cartillage tissue engineering |
| US6656489B1 (en) | 1999-02-10 | 2003-12-02 | Isotis N.V. | Scaffold for tissue engineering cartilage having outer surface layers of copolymer and ceramic material |
| US6197061B1 (en) | 1999-03-01 | 2001-03-06 | Koichi Masuda | In vitro production of transplantable cartilage tissue cohesive cartilage produced thereby, and method for the surgical repair of cartilage damage |
| US6662805B2 (en) | 1999-03-24 | 2003-12-16 | The Johns Hopkins University | Method for composite cell-based implants |
| ES2525553T3 (es) | 1999-03-25 | 2014-12-26 | Metabolix, Inc. | Dispositivos y aplicaciones médicas de polímeros polihidroxialcanoato |
| US6103255A (en) | 1999-04-16 | 2000-08-15 | Rutgers, The State University | Porous polymer scaffolds for tissue engineering |
| US6287340B1 (en) | 1999-05-14 | 2001-09-11 | Trustees Of Tufts College | Bioengineered anterior cruciate ligament |
| GB9912240D0 (en) | 1999-05-27 | 1999-07-28 | Smith & Nephew | Implantable medical devices |
| WO2000073417A1 (en) | 1999-05-27 | 2000-12-07 | The Research Foundation Of State University Of New York | In vitro cell culture device including cartilage and methods of using the same |
| DE19926083A1 (de) | 1999-06-08 | 2000-12-14 | Universitaetsklinikum Freiburg | Biologisches Gelenkkonstrukt |
| US6667049B2 (en) | 1999-06-14 | 2003-12-23 | Ethicon, Inc. | Relic process for producing bioresorbable ceramic tissue scaffolds |
| US20040059416A1 (en) | 1999-06-22 | 2004-03-25 | Murray Martha M. | Biologic replacement for fibrin clot |
| US6333029B1 (en) * | 1999-06-30 | 2001-12-25 | Ethicon, Inc. | Porous tissue scaffoldings for the repair of regeneration of tissue |
| US6306424B1 (en) | 1999-06-30 | 2001-10-23 | Ethicon, Inc. | Foam composite for the repair or regeneration of tissue |
| US6652872B2 (en) | 1999-07-06 | 2003-11-25 | Ramat At Tel Aviv University Ltd. | Scaffold formed of tissue treated to eliminate cellular and cytosolic elements |
| US6179840B1 (en) | 1999-07-23 | 2001-01-30 | Ethicon, Inc. | Graft fixation device and method |
| US6499486B1 (en) | 1999-07-29 | 2002-12-31 | Ethicon, Inc. | Method for reconstructing a ligament |
| AU6527000A (en) | 1999-08-06 | 2001-03-05 | Cook Biotech, Incorporated | Tubular graft construct |
| DE60017757T2 (de) | 1999-08-30 | 2006-01-12 | I.D.M. Immuno-Designed Molecules | Humanisierte biomaterialien enthaltend monozyten oder makrophagen, ein verfahren zu ihrer herstellung und ihre anwendungen |
| JP2001129073A (ja) * | 1999-11-02 | 2001-05-15 | Olympus Optical Co Ltd | 骨補填材および骨補填材注入具 |
| WO2001034065A1 (en) | 1999-11-12 | 2001-05-17 | James Cho Hong Goh | Tissue-engineered ligament |
| CA2369076A1 (en) * | 2000-02-05 | 2001-08-09 | Vertex Pharmaceuticals Incorporated | Pyrazole compositions useful as inhibitors of erk |
| EP1286707A2 (en) | 2000-02-18 | 2003-03-05 | Regeneration Technologies, Inc. | Implantable tissues infused with growth factors and other additives |
| US20020133229A1 (en) | 2000-03-24 | 2002-09-19 | Laurencin Cato T. | Ligament and tendon replacement constructs and methods for production and use thereof |
| US6629997B2 (en) | 2000-03-27 | 2003-10-07 | Kevin A. Mansmann | Meniscus-type implant with hydrogel surface reinforced by three-dimensional mesh |
| WO2001082994A1 (en) | 2000-04-28 | 2001-11-08 | Curis, Inc. | Methods and reagents for tissue engineering of cartilage in vitro |
| GB0011244D0 (en) | 2000-05-11 | 2000-06-28 | Smith & Nephew Inc | Tissue regrafting |
| AU2001265141A1 (en) | 2000-05-26 | 2001-12-11 | University Of Virginia Patent Foundation | Multifunctional periodic cellular solids and the method of making thereof |
| US6991652B2 (en) | 2000-06-13 | 2006-01-31 | Burg Karen J L | Tissue engineering composite |
| US20010053839A1 (en) | 2000-06-19 | 2001-12-20 | Koken Co. Ltd. | Biomedical material and process for making same |
| EP1167517A1 (en) | 2000-06-22 | 2002-01-02 | IsoTis N.V. | Tissue engineering |
| KR100880622B1 (ko) * | 2000-06-29 | 2009-01-30 | 바이오신텍 캐나다 인코포레이티드 | 연골 및 다른 조직의 복구 및 재생용 조성물 및 방법 |
| WO2002005750A2 (en) | 2000-07-19 | 2002-01-24 | Osteotech, Inc. | Osteoimplant and method of making same |
| US6638312B2 (en) | 2000-08-04 | 2003-10-28 | Depuy Orthopaedics, Inc. | Reinforced small intestinal submucosa (SIS) |
| US8366787B2 (en) | 2000-08-04 | 2013-02-05 | Depuy Products, Inc. | Hybrid biologic-synthetic bioabsorbable scaffolds |
| MXPA03002414A (es) | 2000-09-18 | 2004-07-08 | Organogenesis Inc | Protesis con injerto de hoja plana tratada por bioingenieria y su uso. |
| US6752831B2 (en) | 2000-12-08 | 2004-06-22 | Osteotech, Inc. | Biocompatible osteogenic band for repair of spinal disorders |
| US8758438B2 (en) | 2000-12-08 | 2014-06-24 | Warsaw Orthopedic, Inc. | Implant for orthopedic applications |
| CA2365376C (en) | 2000-12-21 | 2006-03-28 | Ethicon, Inc. | Use of reinforced foam implants with enhanced integrity for soft tissue repair and regeneration |
| US20020127265A1 (en) | 2000-12-21 | 2002-09-12 | Bowman Steven M. | Use of reinforced foam implants with enhanced integrity for soft tissue repair and regeneration |
| US6599323B2 (en) | 2000-12-21 | 2003-07-29 | Ethicon, Inc. | Reinforced tissue implants and methods of manufacture and use |
| US6852330B2 (en) | 2000-12-21 | 2005-02-08 | Depuy Mitek, Inc. | Reinforced foam implants with enhanced integrity for soft tissue repair and regeneration |
| AU2002247044B2 (en) | 2001-01-30 | 2006-11-16 | Orthogene, Inc. | Compositions and methods for the treatment and repair of defects or lesions in articular cartilage using synovial-derived tissue or cells |
| US20020176893A1 (en) | 2001-02-02 | 2002-11-28 | Wironen John F. | Compositions, implants, methods, and kits for closure of lumen openings, repair of ruptured tissue, and for bulking of tissue |
| AUPR289601A0 (en) * | 2001-02-05 | 2001-03-01 | Commonwealth Scientific And Industrial Research Organisation | Method of tissue repair |
| US20030050709A1 (en) | 2001-02-23 | 2003-03-13 | Ulrich Noth | Trabecular bone-derived human mesenchymal stem cells |
| US6827743B2 (en) | 2001-02-28 | 2004-12-07 | Sdgi Holdings, Inc. | Woven orthopedic implants |
| US7252982B2 (en) | 2001-03-15 | 2007-08-07 | Massachusetts Institute Of Technology | Tissue engineering enhanced by the transfer of a growth factor gene |
| FI20010540A0 (fi) | 2001-03-16 | 2001-03-16 | Yli Urpo Antti | Komposiitti pehmyt- ja kovakudosvammojen korjaamiseksi ja mainitun komposiitin käyttö |
| US6378572B1 (en) | 2001-03-28 | 2002-04-30 | Siemens Corporate Research, Inc. | Image processing system for inspection of tablets in slab filler packaging machines |
| US6656488B2 (en) | 2001-04-11 | 2003-12-02 | Ethicon Endo-Surgery, Inc. | Bioabsorbable bag containing bioabsorbable materials of different bioabsorption rates for tissue engineering |
| US6699252B2 (en) | 2001-04-17 | 2004-03-02 | Regeneration Technologies, Inc. | Methods and instruments for improved meniscus transplantation |
| US6444222B1 (en) | 2001-05-08 | 2002-09-03 | Verigen Transplantation Services International Ag | Reinforced matrices |
| RU2187261C1 (ru) | 2001-05-21 | 2002-08-20 | Новокузнецкий государственный институт усовершенствования врачей | Способ лечения деформации носовой перегородки у спортсменов |
| DE60239674D1 (de) | 2001-05-25 | 2011-05-19 | Conformis Inc | Verfahren und zusammensetzungen zur reparatur der oberfläche von gelenken |
| US6626950B2 (en) | 2001-06-28 | 2003-09-30 | Ethicon, Inc. | Composite scaffold with post anchor for the repair and regeneration of tissue |
| JP3646162B2 (ja) | 2001-07-04 | 2005-05-11 | 独立行政法人産業技術総合研究所 | 軟骨組織の再生用移植体 |
| ATE499908T1 (de) | 2001-07-16 | 2011-03-15 | Depuy Products Inc | Gerät zur reparatur von knorpelmaterial |
| AU2002320610A1 (en) | 2001-07-16 | 2003-03-03 | Altertek/Bio Inc | Tissue engineered heart valve |
| JP2004535245A (ja) | 2001-07-16 | 2004-11-25 | デピュイ・プロダクツ・インコーポレイテッド | 多孔質細胞外基質支持骨格材料および方法 |
| AU2002354911B2 (en) | 2001-07-16 | 2007-08-30 | Depuy Products, Inc. | Meniscus regeneration device and method |
| WO2003007788A2 (en) | 2001-07-16 | 2003-01-30 | Depuy Products, Inc. | Unitary surgical device and method |
| JP4197160B2 (ja) | 2001-07-16 | 2008-12-17 | デピュイ・プロダクツ・インコーポレイテッド | 軟骨修復および再生用の支持骨格材料および方法 |
| US7153518B2 (en) | 2001-08-27 | 2006-12-26 | Regeneration Technologies, Inc. | Processed soft tissue for topical or internal application |
| BR0214217A (pt) | 2001-11-16 | 2004-09-21 | Childrens Medical Center | Aumento de função de órgão |
| US7326426B2 (en) | 2002-03-29 | 2008-02-05 | Ethicon, Inc. | Compositions and medical devices utilizing bioabsorbable liquid polymers |
| JP2003320008A (ja) * | 2002-04-30 | 2003-11-11 | Olympus Optical Co Ltd | 生体組織補填体およびその製造方法 |
| JP2004008437A (ja) | 2002-06-06 | 2004-01-15 | Olympus Corp | 培養骨 |
| DE10234742A1 (de) | 2002-07-30 | 2004-02-19 | Bionethos Holding | Verfahren und Vorrichtung zum Züchten von Zellen |
| US20040062753A1 (en) | 2002-09-27 | 2004-04-01 | Alireza Rezania | Composite scaffolds seeded with mammalian cells |
| US20040078090A1 (en) | 2002-10-18 | 2004-04-22 | Francois Binette | Biocompatible scaffolds with tissue fragments |
| US7824701B2 (en) | 2002-10-18 | 2010-11-02 | Ethicon, Inc. | Biocompatible scaffold for ligament or tendon repair |
| JP2004195103A (ja) | 2002-12-20 | 2004-07-15 | Japan Tissue Engineering:Kk | 口腔用移植片 |
| US8940292B2 (en) | 2003-01-28 | 2015-01-27 | Wake Forest University Health Sciences | Enhancement of angiogenesis to grafts using cells engineered to produce growth factors |
| US8197837B2 (en) | 2003-03-07 | 2012-06-12 | Depuy Mitek, Inc. | Method of preparation of bioabsorbable porous reinforced tissue implants and implants thereof |
| US7368124B2 (en) | 2003-03-07 | 2008-05-06 | Depuy Mitek, Inc. | Method of preparation of bioabsorbable porous reinforced tissue implants and implants thereof |
| US7067123B2 (en) | 2003-04-29 | 2006-06-27 | Musculoskeletal Transplant Foundation | Glue for cartilage repair |
| EP2399990B1 (en) | 2003-06-27 | 2015-07-22 | DePuy Synthes Products, Inc. | Cells derived from post-partum umbilical cord for use in treatment of disease of the heart and circulatory system |
| US8226715B2 (en) | 2003-06-30 | 2012-07-24 | Depuy Mitek, Inc. | Scaffold for connective tissue repair |
| US7262020B2 (en) | 2003-07-03 | 2007-08-28 | The Regents Of The University Of California | Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol |
| US10583220B2 (en) | 2003-08-11 | 2020-03-10 | DePuy Synthes Products, Inc. | Method and apparatus for resurfacing an articular surface |
| US7316822B2 (en) | 2003-11-26 | 2008-01-08 | Ethicon, Inc. | Conformable tissue repair implant capable of injection delivery |
| EP1537839A1 (en) | 2003-12-02 | 2005-06-08 | Dr. h. c. Robert Mathys Foundation | Prosthetic device for cartilage repair |
| US7901461B2 (en) | 2003-12-05 | 2011-03-08 | Ethicon, Inc. | Viable tissue repair implants and methods of use |
| US11395865B2 (en) | 2004-02-09 | 2022-07-26 | DePuy Synthes Products, Inc. | Scaffolds with viable tissue |
| JP4292094B2 (ja) | 2004-02-24 | 2009-07-08 | グンゼ株式会社 | 神経再生チューブ |
| US8657881B2 (en) | 2004-04-20 | 2014-02-25 | Depuy Mitek, Llc | Meniscal repair scaffold |
| US8221780B2 (en) | 2004-04-20 | 2012-07-17 | Depuy Mitek, Inc. | Nonwoven tissue scaffold |
| US8137686B2 (en) | 2004-04-20 | 2012-03-20 | Depuy Mitek, Inc. | Nonwoven tissue scaffold |
| HUE026731T2 (en) | 2004-10-20 | 2016-07-28 | Ethicon Inc | Reinforced, absorbable, multilayer tissue for application in medical devices and preparation process |
| CA2589041C (en) | 2004-12-23 | 2019-08-20 | DePuy Synthes Products, Inc. | Postpartum cells derived from umbilical cord tissue, and methods of making and using the same |
| US20060280768A1 (en) | 2005-06-13 | 2006-12-14 | Julia Hwang | Meniscal repair device and method |
| US20060293760A1 (en) | 2005-06-24 | 2006-12-28 | Dedeyne Patrick G | Soft tissue implants with improved interfaces |
| US20110110958A1 (en) | 2007-09-11 | 2011-05-12 | University Of Florida Research Foundation | Compositions and methods for the treatment of neoplasia |
-
2003
- 2003-11-26 US US10/723,982 patent/US7316822B2/en not_active Expired - Lifetime
-
2004
- 2004-11-03 AU AU2004226939A patent/AU2004226939B2/en not_active Ceased
- 2004-11-04 CA CA2487029A patent/CA2487029C/en not_active Expired - Fee Related
- 2004-11-25 JP JP2004340887A patent/JP4628756B2/ja not_active Expired - Fee Related
- 2004-11-25 DE DE602004029542T patent/DE602004029542D1/de not_active Expired - Lifetime
- 2004-11-25 EP EP04257327A patent/EP1535633B1/en not_active Expired - Lifetime
- 2004-11-25 EP EP10075307.8A patent/EP2248540B1/en not_active Expired - Lifetime
-
2007
- 2007-11-29 US US11/947,384 patent/US7875296B2/en not_active Expired - Lifetime
-
2010
- 2010-12-29 US US12/980,544 patent/US8137702B2/en not_active Expired - Lifetime
-
2012
- 2012-02-27 US US13/406,230 patent/US8496970B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP2248540B1 (en) | 2019-02-27 |
| EP1535633B1 (en) | 2010-10-13 |
| CA2487029A1 (en) | 2005-05-26 |
| EP2248540A1 (en) | 2010-11-10 |
| JP2005152653A (ja) | 2005-06-16 |
| JP4628756B2 (ja) | 2011-02-09 |
| EP1535633A1 (en) | 2005-06-01 |
| CA2487029C (en) | 2012-08-14 |
| US20120156265A1 (en) | 2012-06-21 |
| US7316822B2 (en) | 2008-01-08 |
| US8496970B2 (en) | 2013-07-30 |
| US20050113937A1 (en) | 2005-05-26 |
| DE602004029542D1 (de) | 2010-11-25 |
| AU2004226939A1 (en) | 2005-06-09 |
| US8137702B2 (en) | 2012-03-20 |
| US7875296B2 (en) | 2011-01-25 |
| US20080071385A1 (en) | 2008-03-20 |
| US20110097381A1 (en) | 2011-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2004226939B2 (en) | Conformable tissue repair implant capable of injection delivery | |
| US20220331491A1 (en) | Scaffolds with viable tissue | |
| JP5345573B2 (ja) | 組織フラグメントを伴う生体相容性の支持骨格装置 | |
| JP4623954B2 (ja) | 靭帯または腱の修復用の生体相容性の支持骨格装置 | |
| US11357889B2 (en) | Native soft tissue matrix for therapeutic applications | |
| EP1537883B1 (en) | Implants comprising viable tissue for repairing a tissue injury or defect | |
| US10583220B2 (en) | Method and apparatus for resurfacing an articular surface | |
| EP3281605A1 (en) | Acellular matrix implants for treatment of articular cartilage, bone or osteochondral defects and injuries and a method for use thereof | |
| HUP0401450A2 (hu) | Eljárás autológ transzplantációra | |
| Maciej et al. | Culture of human autologous chondrocytes on polysulphonic membrane–preliminary studies |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |